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INTRODUCTION
Killer yeasts secrete polypeptide toxins which kill sensi-
tive cells of their own species and frequently those of other
species and genera of yeast (Fig. 1). This phenomenon has
been observed in many of the yeast genera investigated, but
its prevalence varies widely among natural isolates (111, 116,
130, 170). Although a majority of natural isolates apparently
lack both toxin production and the associated specific toxin
immunity, this must be interpreted cautiously, since assays
for both toxin production and immunity require choice of an
appropriate sensitive strain and determination of optimal
conditions for toxin activity. Nevertheless, it seems that,
whereas toxin production is probably important in yeast
ecology, the ecological advantage conferred by toxin pro-
duction is seldom paramount, or their determinants are
unstable, or such production is associated with deleterious
effects. Although this uncertainty reflects a lack of data on
the persistence of killers in the wild, no deleterious effects
are known, and their genetic determinants are stable in the
laboratory. Low prevalence may indicate that yeast killers
are inefficient assassins. Their determinants might often be
maintained as parasitic passengers rather than as selected,
offensive machinery essential to survival in internecine
warfare.
In the few instances where killer determinants have been
identified, they are cytoplasmically inherited (7, 46, 127),
double-stranded (ds) RNA (4, 6, 95, 142) or DNA (53)
plasmids which encode toxin precursors (11, 51) and which
are dependent on a similar plasmid for maintenance. The
basis of this dependency is known only for the Saccharomy-
ces cerevisiae killer plasmid M-dsRNAs. These dsRNAs are
found only in cells also containing an additional dsRNA
species called L. Both types of dsRNA exist in cytoplasmic
virus-like particles (VLPs) (22, 58), and both dsRNAs re-
quire a protein encoded by the L-dsRNA (62) for encapsida-
tion (13, 55). Killers are a minority among natural S.
cerevisiae isolates, although most strains contain L-
dsRNAs. Such strains are sensitive nonkillers. The helper L-
dsRNA plasmids, unlike the killer determinants, have no
known dependence on other plasmids, confer no known
phenotype on the host cell apart from their effects on M-
dsRNA maintenance, and, when alone, appear to exist as
truly parasitic entities.
Clear parallels exist between the secretion of yeast killer
toxins and the production of bacteriocins. Production of
both is associated with specific immunity, and toxicity is
restricted to similar cell types. Killer yeast strains might,
therefore, more properly be called mycocinogenic strains
and their toxins, mycocins. However, the original nomencla-
ture is now well established and, as pointed out by Bussey
(23), has helped to bring an esoteric aspect of yeast molecu-
lar biology to the attention of a broad range of scientists.
In this review we will focus on the molecular biology of
the most intensively investigated killer system, the M1-
dsRNA-determined Kl killer system of S. cerevisiae. We
hope to demonstrate the relevance of this system to many of
the vital issues in yeast and general eucaryotic molecular
biology.
It should be emphasized that cytoplasmic dsRNA species
have been shown to determine the killer phenotype only in
Saccharomyces sp. and Ustilago (73) sp. strains. Only in one
other species, Kluyveromyces lactis (51), has cytoplasmic
inheritance of the phenotype and the nature of its determi-
nant (one of two linear dsDNA species [53]) been clearly
demonstrated. Brief summaries of recent information on the
K. lactis and Ustilago maydis systems are included, because
of their comparative value and intrinsic interest.
KILLER dsRNAs, MYCOVIRUSES OR ENCAPSIDATED
PLASMIDS?
The existence of cytoplasmic VLPs containing dsRNAs
was well established in the mycoviruses offilamentous fungi
(85, 86) well before the discovery in 1963 (M. Makower and
E. A. Bevan, Proc. Int. Congr. Genet. XI 1:202, 1963) of the
killer phenotype in laboratory strains of S. cerevisiae. These
mycovirus VLPs were found to contain a limited number of
capsid proteins and an associated dsRNA transcriptase
activity (21) and to consist of a population of individually
encapsidated, apparently interdependent dsRNA species.
These properties led to their designation as fungal "virus-
es."1
In considering interactions between the multiple dsRNA
components of mycoviruses, it should be remembered that,
whereas the Reoviridae and other dsRNA viruses of higher
eucaryotic cell types (reviewed in reference 36) contain a
single copy of each of their component dsRNA segments in
each of their virus particles, ensuring equimolar representa-
tion, mycovirus dsRNAs are under no such numerical re-
straint, so that differential demand for gene products can be
reflected in the relative copy numbers of the relevant
dsRNAs.
When the yeast killer phenotype was shown to be associ-
ated with particular dsRNA species (M1, etc.) (6, 95, 131,
142), which were later shown to be present in cytoplasmic
VLPs (22, 58), it became clear that the killer phenotype was
an attribute of a yeast mycovirus which, following the
established nomenclature, was called the S. cerevisiae "Vi-
rus," ScV (62). The VLPs containing various M- and L-
dsRNA species can, therefore, be designated ScV-M1, ScV-
LlA, etc., since reciprocal interdependence between these
species apparently does not exist (see below, "Role of L-
dsRNAs in VLP Capsid Production and M1-dsRNA Mainte-
nance").
No mycovirus, including the yeast killer system, has been
shown to be capable of extracellular transmission. One
recent report of transmission of the dsRNAs of Helmintho-
sporium victoria would be an exception, if confirmed (see
below, "Effects of dsRNA Mycoviruses in Pathogenic Fun-
gi") (48). On the contrary, mycoviruses and the killer
dsRNAs are stably maintained, at relatively constant copy
number, by vertical transmission. Transmission occurs only
by cytoplasmic mixing during budding, mating, or other
natural or artificial forms of cell fusion. The S. cerevisiae
dsRNA killer determinants may thus be regarded as virus-
like plasmids. They clearly possess properties relevant to
both the truly infectious dsRNA viruses (36) and to plasmids
of eucaryotic cells. Their genetic analysis resembles that of
multicopy cytoplasmic plasmids, and for the best-studied
species (M1-, M2-, and LA-dsRNAs), their dependence on
multiple nuclear genetic loci clearly demonstrates their lack
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FIG. 1. Expression of killer and immune phenotypes, in standard plate assays, of a standard killer containing Ml-dsRNA and of
transformants containing M1-cDNA. (Upper) To test killer activity, strains were patched onto a lawn of S. cerevisiae S6, a standard sensitive
strain lacking M-dsRNA, on pH 4.7 medium. Killing is indicated by a clear zone of growth inhibition surrounding the patch. Each pair of
panels shows the result of growth on low-phosphate (left) and high-phosphate (right) medium to test for repressibility by phosphate. (I)
Control of sensitive strain S6. (J) Standard killer strain K12-1 (not repressible). (A through H) Sensitive strain transformed with eight plasmids
(YGB-1 to -16) in which the preprotoxin gene of M1-cDNA is under control of the phosphate-repressible PHO-5 promoter (see text, "In Vivo
Expression of Preprotoxin cDNAs"). All transformants are repressible killers. (Lower) Lawns of strains to be tested for immunity were
exposed to patches of killer strain K12-1 (CD GH KL) or control patches of sensitive strain S6 (AB EF IJ). (A through D) Lawns of strain
K12-1; (I through L) lawns of strain S6; (E through H) lawns of the transformant (YGB-16) shown in upper (H). For each set, the left pair was
grown on high phosphate pH 4.7 medium, and the right pair was grown on low phosphate medium. Strain K12-1 is immune on both media, but
the transformant is only immune on derepressing (low-phosphate) medium.
of autonomy. The relatively stable copy number of these
dsRNAs implies some degree of coupling of VLP replication
to the yeast cell cycle. Partition of VLPs during mitotic and
meiotic cell division may also be controlled (5).
The S. cerevisiae killer system has become the best
understood of the mycoviruses, primarily because of the
facility of genetic and biochemical analyses in its host and
the simplicity of scoring for killer toxin production and toxin
immunity. Genetic analysis of this system has been exten-
sive (reviewed in references 152, 156, 158, 160) and illus-
trates the complexity of nuclear-cytoplasmic and plasmid-
plasmid interactions involved in maintenance and expression
of the killer M-dsRNAs. Relationships observed between
different ScVs or dsRNA species include dependency, indif-
ference, and incompatibility or exclusion. The killer system
is now a prime model for the investigation of such phenome-
na in eucaryotic microorganisms. Genetic analysis of this
system continues to reveal levels of complexity that outstrip
biochemical analysis of their implications, although recent
advances have clarified many previously obscure issues.
Description of these findings is the major rationale for
writing a new review of this subject.
Maturation of preprotoxin, the product of the M1-dsRNA
toxin gene, is a useful model for the complex protein
secretion pathway in yeast (see "'Structure of the M1-dsRNA
Preprotoxin Gene and Steps in Toxin Maturation"). At the
same time, recent data on the mode of action of the toxin
suggest that toxin and immunity determinants will be useful
VOL. 48, 1984
 o
n
 June 16, 2019 by guest
http://m
m
br.asm
.org/
D
ow
nloaded from
 
128 TIPPER AND BOSTIAN
probes of yeast cytoplasmic membrane function and models
for transmembrane ionic pore formation. It also seems likely
that analysis of MAK and SKI gene functions (see "Nuclear
Mutations Affecting M-dsRNA Maintenance") will yield
valuable insights into the molecular biology of gene expres-
sion in yeasts.
Several excellent reviews of this field already exist, and
the reader is especially directed to recent reviews by
Wickner (160) and Bussey (23) for more extensive coverage
of information in their areas of expertise, respectively, the
genetics and physiology of the S. cerevisiae killer system.
Older reviews by Wickner (156) and Bruenn (17, 112) are
also valuable summaries of genetic and molecular aspects of
the field.
VARIETIES AND PREVALENCE OF YEAST KILLERS
The killer phenotype was first described in laboratory
strains of S. cerevisiae by Makower and Bevan (M. Ma-
kower and E. A. Bevan, Proc. Int. Congr. Genet. XI 1:202,
1963). Killing was found to be caused by an exocellular,
heat- and protease-sensitive toxin (169) that was only active
and reasonably stable in the pH range of 4.2 to 4.7. This is
now known to be close to its pl of 4.5 (107). Several more
recent surveys of yeast strain collections and natural isolates
have demonstrated the presence of similar phenomena in
many genera (29, 65, 90, 92, 111, 116, 130, 170).
Most surveys have used rich agar media containing meth-
ylene blue in the pH range of 4.2 to 4.7, seeded or thinly
spread with potentially sensitive tester strains and heavily
streaked with potential killers. Zones of growth inhibition
surrounding the latter, bounded by blue-stained dead yeast
cells, indicates killer toxin secretion. Figure 1 shows two
natural Kl killer strains and an artificial killer strain contain-
ing no killer dsRNA but containing, instead, a phosphate-
repressible cDNA copy of such a dsRNA (see "In Vivo
Expression of Preprotoxin cDNAs").
An S. cerevisiae strain sensitive to the type Kl S. cerevisi-
ae killers has often been used for initial screening, followed
by cross-testing of killers to define immunity patterns. Such
cross-testing matrices (116, 130, 170) usually demonstrate
that, within a given genus, each killer strain is immune to its
own toxin, but sensitive to toxins of other immune classes.
This simple pattern is complicated by variation in the
sensitivity of nonproducing strains, or of strains which all
produce a single toxin type, to other toxins. As pointed out
by Young and Yagiu (170), such strain variation in sensitivity
is probably a result of nuclear mutations to resistance.
It is useful to distinguish semantically between killer-
specific, plasmid-determined immunity and less specific
resistance related to nuclear genotype. For example, where-
as intergeneric killing does occur, many yeast strains are
intrinsically resistant to killer toxins produced by members
of other genera. Known S. cerevisiae nuclear mutations
(krel,2,3) leading to resistance to M1-dsRNA-determined Kl
toxin also confer resistance to a broad range of other toxin
types (1, 26). However, neutral strains carrying a mutant M1-
dsRNA which fails to cause toxin production (7, 24) retain
immunity to the Kl toxin only.
The most thorough survey of killer types was performed
by Young and Yagiu (170), using 20 killer strains found
earlier in the British National Collection of Yeast Cultures
(NCYC) (111). Species in 7 of 28 genera produced toxin
active against an S. cerevisiae strain. Thirteen negative
genera were represented by only one or two species, and
since prevalence of killers among positive genera varied
from 2 of 51 (Candida) to 12 of 29 (Hansenula), it seems
likely that broader screening would turn up killers in several
other genera. Exocellular toxins produced by the killers
could be distinguished on the basis of pH optima, tempera-
ture stability, and relative susceptibility to proteases, al-
though all were protease sensitive and optimally active
below pH 5. Ten toxin types (Ki to K10) were distinguished
by killer toxin and immunity specificities, including three
(Ki, K2, and K3) in Saccharomyces sp. strains. Kl is the
type originally recognized in laboratory strains of S. cerevisi-
ae (6, 7; Makower and Bevan, Proc. Int. Congr. Genet. XI
1:202, 1963). K2 killers were first recognized in Russian wine
yeast and were shown to be capable of killing Kl killers (97,
98). Similar strains were found as contaminants of a two-
stage continuous beer fermentation (88) and were later
shown to belong to the same K2 killer group (116). K3 is
currently defined by strain 761 of S. capensis (170). Ki, K2,
and K3 killers were found to carry physically distinct species
of M-dsRNA (1.9, 1.7, and 1.5 kilobases [kb], respectively)
(170). Minor differences were also reported in the mobilities
of their associated L-dsRNAs (170). The plasmid nature of
the M1-dsRNA determinant of the Kl killer strains had been
previously indicated by demonstration that it could be cured
by growth at high temperature (151) or in the presence of
subinhibitory concentrations of cycloheximide (46) or 5-
fluorouracil (95, 99) with concomitant loss of the killer
character. This was also shown to be true for the K2 and K3
killer types (170). No dsRNA species were detected in any
member of other killer classes, and none of these killers were
curable under these conditions.
A homothallic wine yeast (S. cerevisiae) has recently been
described (43) that kills both Ki and K2 S. cerevisiae killers.
After nitrosoguanidine mutagenesis, strains killing both,
called "K3," and strains bearing the K2 killer phenotype
were found. The original strain contained two M-dsRNA
species of about 2.0 and 1.5 kb. The K2 derivatives con-
tained the 1.5-kb species, presumably closely related to 1.7-
kb M2-dsRNA, whereas the K3 derivatives contained the
2.0-kb species. This is apparently a new killer plasmid,
compatible with M2-dsRNA. It is considerably larger than
the S. capensis M3-dsRNA of Young and Yagiu (170), so it is
probably a fourth type of M-dsRNA, though this has not
been tested directly. If the unusual killer toxin produced by
S. cerevisiae strain 28 (110) is associated with a unique
dsRNA, this will presumably be a fifth type. This strain
produces an unusually stable toxin with a pH optimum of 5,
higher than for any other known killer. Its genetic determi-
nant is unknown (110).
Killing of S. cerevisiae by Torulopsis glabrata strain
ATCC 15126 was demonstrated in 1975 (29, 30). Its toxin,
dubbed pool efflux-stimulating toxin (PEST), acts very much
like the other yeast killer toxins (27, 77, 89) except that its
action is apparently independent of energy consumption by
the victim (124). The toxin specificity of this strain differs
from all of those tested by Young and Yagiu (170), including
their K4 strain, T. glabrata 388. It was called "Tox 3" by
Rogers and Bevan (116), but has been appended by Wickner
(156) to the Young and Yagiu classification (170) as Kll
specificity.
Extensive investigations of killing in natural yeast isolates
by Middelbeek et al. (89-94, 130) has almost certainly
uncovered other unique killer types. However, no complete
comparison of these strains with the Kl to Kll types (156)
has been reported, nor has the nature of the genetic determi-
nants or their mode of transmission been reported for any of
these isolates. Among 157 natural isolates, 17%, represent-
ing seven separate genera, were killers of S. cerevisiae (130).
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Among yeast genera commonly found as opportunistic
human pathogens, Kl killers were first observed in Candida
spp. by Mitchell et al. (Abstr. IV Int. Congr. Yeast Genet.
Mol. Biol., p. 24, 1975), and Kll was seen in Torulopsis sp.
by Bussey and Skipper (29). An extensive survey by Middel-
beek et al. (91), using a wide variety of killer strains, showed
sensitivity among 116 of 142 strains of Candida and Torulop-
sis spp., especially to toxins produced by strains of Hansen-
ula sp. (130) and Pichia kluyveri (90). Sensitivity is now
being used epidemiologically for typing of fungal pathogens
(113). A much lower prevalence of sensitivity was found in a
similar survey by Kandel and Stern (69). However, the latter
study used only S. cerevisiae and Torulopsis sp. strains as
sources of toxin. Cryptococcus sp. strains were found to be
sensitive only to toxins produced by other cryptococci and
by certain Torulopsis sp. strains (92).
MODE OF ACTION OF KILLER TOXIN
The mode of action of killer toxins has been studied
extensively in the S. cerevisiae Kl system, using strain K12-
1, a normal laboratory strain killer, or derivatives of strain
T158c. This strain contains a mutant "superkiller" form of
MI-dsRNA encoding normal quantities of a more stable
toxin (107) (see below, subsection "dsRNA Determinants").
The toxin of strain K12-1 consists of two polypeptide
components (10), barely resolvable on reducing gels into
slower (a) and faster (,B) migrating species of about 9.5 and
9.0 kilodaltons (kd) (Fig. 2). These components are disulfide
linked and run as a 17-kd dimer on nonreducing gels. It is
assumed, but not proven, that this is an ot3 dimer. Strain
M5c contains the T158c superkiller M1-dsRNA (143) and its
a component migrates more slowly than that of K12-1 (Fig.
2), although its 1 component migrates identically. Sequence
analysis of cDNAs (10, 125; see "In Vivo Expression of
Preprotoxin cDNAs") confirms that the only amino acid
variations occur in the a component. In strain M5c, secreted
toxin comprises about 5% of the total secreted protein (Fig.
2) (107).
Type Kl toxin is irreversibly inactivated at pH values over
6.5, is most stable at pH values near its pl (4.5), and is
inactivated with a half-life of about 60 min in culture media
of normal strains (31). Degradation is inhibited by phenyl-
methylsulfonyl fluoride and a mutation (called skiS) results in
loss of this phenylmethylsulfonyl fluoride-inhibitable exocel-
lular protease and markedly enhanced toxin accumulation,
equivalent to that seen in the presence of phenylmethylsul-
fonyl fluoride in normal strains (31). A considerable fraction
of toxin, partially purified according to size, is inactive.
1,613-D-Glucan affinity (64) and controlled-pore glycerated
glass (107) columns separate active toxin (10 to 30% of the
total) from inactive toxin, with essentially complete reten-
tion of activity. However, the two fractions are indistin-
guishable on gels (25) or by interaction with polyvalent
toxin-specific antisera (11).
The a and 1 components of toxin have a high content of
hydrophobic and charged amino acids (10), with a combined
pl of 4.5 (107), and are stabilized by 15% glycerol at this pH
(107). Toxin action involves an initial, rapid, energy-inde-
pendent binding of toxin to a cell wall receptor (1, 26) that
has now been identified as a 1,6f-D-glucan (64). Both
sensitive and immune (Ml-dsRNA containing) cells have a
large number of such receptors, whereas mutations in either
of two nuclear loci (krel and kre2) (1) drastically reduce cell
wall binding and modify 1,613-D-glucan content. kre mutants
are resistant to a wide range of killer toxins, suggesting a
common initial binding step in their action (1, 26, 64).
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FIG. 2. Fractionation of total exocellular proteins and partially
purified toxins from killer strains by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (10). (Lanes a, b, g, h) Marker
proteins; (lanes c, d) purified and crude toxin from strain M5c,
containing the skiS mutation (31) and superkiller T158c M1-dsRNA
mutant, modified in the a-toxin component sequence (see text, "In
Vivo Expression of Preprotoxin cDNAs"); (lanes e, f) purified and
crude toxin from wild-type killer strain K12-1.
After binding to the wall, an energy-dependent process
(124) transfers toxin to its site of action, the cytoplasmic
membrane. As few as 3 x 104 of the 107 cell wall-binding
sites need to be occupied for this step and lethality to occur
(23). krel and kre2 mutant cells have toxin-sensitive proto-
plasts, whereas the protoplasts of immune, toxin-producing
cells retain their immunity (28). Mutants in a third nuclear
gene, kre3 (1), are resistant in spite of normal wall binding
and their protoplasts remain resistant (H. Bussey, personal
communication).
The non-saturability of immunity argues against direct
interaction of toxin and immunity determinants. This and the
existence of the kre3 and rex mutants (in which killer
plasmid-carrying strains kill themselves; 150) suggest the
existence of a receptor in the membrane for the second stage
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130 TIPPER AND BOSTIAN
of toxin action. At present it is not known whether both a
and ,B toxin components interact with this putative receptor,
or whether one toxin component is required only for initial
binding to the wall, serving as a concentrated source of the
lethal component for delivery to the membrane (see "Se-
quence of the M1-Pl Preprotoxin Gene," subsection "Func-
tional Analysis of the Toxin Subunit Structure and y").
The events leading to cell death also require expenditure
of metabolic energy (27). Killing is only apparent after a lag
period which is dependent on medium composition and
growth phase. The effects of toxin are reversible during this
lag, and stationary-phase cells are relatively resistant to
toxin. In growing cells, inhibition of net proton efflux (39)
occurs rapidly, coincident with inhibition of K+ influx and
coupled amino acid-proton transport activity (38). All of
these effects are apparently due to a rapidly induced increase
in the permeability of the cytoplasmic membrane to protons
(38). The proton extruding ATPase is probably not directly
TABLE 1. Nomenclature for S. cerevisiae killers
Phenotype(s) Definition
Killer.............. Secretion of a polypeptide toxin
that kills sensitive yeast cells
Immune ....... ....... Plasmid-determined resistance
to homologous killer toxin
Resistance.Resistance to a broad range of
toxins, dependent on growth
conditions or nuclear geno-
type (e.g., lack of receptor)
Kl, K2, or K3 .............. Strain having the type 1, 2, or 3
killer phenotype
R .............. Lack of immunity to known
killer toxins
R1+ R2+ R3+......... ..... Immunity to Kl, K2, or K3
toxin, respectively
R1w ..... ......... Weak immunity to Kl toxin
K, .... .......... Production of Kl toxin; ability
to kill R-, R2+, or R3'
strains
K2 .... .......... Production of K2 toxin: ability
to kill R-, R1+, or R3+
strains
K3 .... .......... Production of K3 toxin: ability
to kill R-, R1+, or R2
strains
K1 .............. Superkiller producing more ac-
tive or more stable Kl toxin
(K1+ R1+) (K2+ R2+)............ Normal phenotypes of Kl and
K2 killer strains, respectively
(K- R1+) ........ ...... Neutral phenotype; strain car-
ries a mutant Kl plasmid
(K1+ R1w) ......... ..... Suicidal phenotype; strain car-
ries a mutant Kl plasmid
Exclusion.Interference with replication of
a killer plasmid leading to its
loss by dilution; can be a
consequence of plasmid or
nuclear genotype
Suppressive ........... ... Plasmid causing exclusion
Helper.............. Plasmid preventing exclusion or
enabling replication
Satellite ....... ....... Replication-defective plasmid
dependent on another; e.g.,
ScV-M, is a satellite of ScV-
L1A
VLP ..... ......... Virus-like particle
ScV-L1A............... S. cerevisiae virus containing
LlA-dsRNA in VLPs
affected, but its effects are overwhelmed, leading, over a
period of 40 to 90 min, to a marked drop in intracellular pH,
metabolic inhibition, potassium ion efflux, and cell death
associated with the leakage of metabolic pools such as ATP
(27, 38). Macromolecules do not leak.
Very similar observations have been made with the toxin
from a sake strain of S. cerevisiae (65, 77) which shares Kl
immunity (23). It was also observed with this strain that
Ca2+ ions prevented toxin-induced membrane damage (77).
Recent and extensive investigations of the mode of action
of the purified toxin from P. kluyveri 1002 have extended
these observations. This yeast strain kills S. cerevisiae Kl
killers (90), although it shares most of their killing spectrum
(130). Its relationship to the current killer classification and
the nature of its killer determinant are unknown. Like the
K12-1 toxin, the P. kluyveri toxin is most active and stable at
pH values near its pl of 4.3. It has an apparent molecular
weight of 19,000 and may be a glycoprotein (90). Binding to a
cell wall receptor is energy independent, and when added to
cells pretreated with metabolic inhibitors such as dinitrophe-
nol or antimycin A, cells can be rescued simply by raising
the pH to 7, inactivating cell wall-bound toxin (94). After
energy-dependent insertion into the membrane, killing can
still be reversed for some time, but now requires removal of
toxin and adjusting medium pH and K+ concentrations to
physiological levels (pH 6.5, 50 mM KCI; 89). Cells are still
killed if continuously exposed to toxin under these condi-
tions for 60 min (89, 94) since membrane-associated toxin
apparently remains active at pH 6.5, so that cumulative
damage still occurs. It has recently been shown (68) that this
toxin forms relatively nonselective, ion-permeable channels
in artificial phospholipid bilayer membranes. Similar obser-
vations have been made with the T158c type Kl toxin
(Bussey, personal communication). These observations fur-
ther exemplify the resemblance between the yeast killer
toxins and the El functional class of colicins (119).
As pointed out by Kagan (68), the conductance of killer
toxin channels is approximately 100 times that of colicin El
channels, consistent with the observation that toxin action
on yeast cells, whose volume is about 1,000 times that of an
Escherichia coli cell, like colicin action on E. coli cells, can
cause an immediate leak large enough to inhibit net proton
pumping and to dissipate preexisting membrane potential.
This leak is also large enough to allow the cumulative lethal
effects of leakage to occur within a cell's generation time in
both E. coli and yeasts.
SUMMARY OF PHENOTYPES, dsRNA
DETERMINANTS, AND PLASMID GENOTYPES OF S.
CEREVISIAE KILLERS
Nomenclature
The nomenclature used for killer phenotypes is summa-
rized in Table 1. S. cerevisiae killers of types Kl, K2, and
K3 have immunity to homologous toxin (R1 , R2', and R3'
phenotypes, respectively) and secrete toxins of appropriate
specificity (K1+, K2', and K3', respectively).
Standard genetic tests (see below) distinguish the cyto-
plasmically inherited killer phenotypes determined by multi-
copy plasmid genomes from those phenotypes affecting
killer maintenance and expression which are determined by
nuclear genes subject to Mendelian segregation (MAK, SKI,
etc.; see "Nuclear Mutations Affecting M-dsRNA Mainte-
nance"). (The dominant alleles of yeast nuclear loci are
capitalized [e.g., SKI5].)
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dsRNA KILLER SYSTEM IN YEASTS 131
TABLE 2. dsRNAs in S. cerevisiae killers
dsRNA(s) Definition/comments
Ml 1.9-kb dsRNA; determinant of the K1l R1l pheno-
type
M2 1.7-kb dsRNA; determinant of the K2' R2' pheno-
type
M3 1.5-kb dsRNA; determinant of the K3' R3' pheno-
type
S3 0.73-kb dsRNA derived from M1 by an internal de-
letion
LA 4.7-kb dsRNA competent and required for mainte-
nance of Ml or M2-dsRNAs; requirements for M3
maintenance not determined
LlA 4.7-kb class LA dsRNA found in natural Kl killers;
encodes an 88-kd polypeptide that encapsidates
itself and Ml
L2A 4.7-kb class LA dsRNA found in naturally isolated
type K2 killers; only partly homologous to LlA
but probably has similar functional capabilities;
encodes the 84-kd capsid of its own VLPs
LB, Lc, LBC 4.7-kb dsRNAs found in most Kl and K2 killers;
related to each other but not to LIA or L2A; not
required for, nor probably capable of, mainte-
nance of Ml or M2; encode the 82-kd capsid of
their own VLPs
T, W Minor 2.7- and 2.25-kb dsRNA species of unknown
function present in many S. cerevisiae strains;
unrelated to each other or to other known
dsRNA species
XL Minor dsRNA slightly larger than LIA, occasionally
reported in Kl killers; identity unknown
dsRNA Determinants
The dsRNAs associated with these plasmid phenotypes
are listed in Table 2. The S. cerevisiae system is comprised
of essentially two segments of dsRNA distinguished by size,
L and M, which may exist in multiple subspecies. In
addition, minor species designated T, W, and XL have been
observed in some strains. The products of in vitro translation
of these dsRNAs (after denaturation) and their presumed or
proven in vivo counterparts are shown in Table 3.
Most isolates of S. cerevisiae contain at least one species
of 4.7-kb L-dsRNA. Maintenance of an M-dsRNA is depen-
dent on a subspecies, called LA, in which considerable
variation is found. Variants associated with naturally isolat-
ed type Kl and K2 killers are called LlA and L2A, respective-
ly (Table 2; "Role of L-dsRNA Species in VLP Capsid
Production and M1-dsRNA Maintenance"). A second sub-
species, LBC, is often present as a minor additional compo-
nent. It cannot, by itself, support M-dsRNA maintenance
(Table 2).
Functional Model of Ml-dsRNA
A model of M1-dsRNA is shown in Fig. 3. The relevant
data for its derivation are described elsewhere in this review.
In summary, Ml-dsRNA consists of approximately i.0- and
0.6-kb segments separated by a highly adenine-uracil (AU)-
rich denaturation "bubble" sequence, probably of variable
size (here shown as 200 base pairs [bp]). The longer segment
encodes the toxin precursor, preprotoxin. Preprotoxin, the
primary in vivo translation product of M1-dsRNA tran-
scripts, is believed to be identical to M1-Pl, the product of in
vitro translation of denatured M1-dsRNA (Table 3). The two
disulfide-linked toxin polypeptides, a and 3, are about 9.5
and 9.0 kd, respectively (Table 3) (10). They are separated in
preprotoxin by a segment called -y, predicted to be the
immunity determinant, and are preceded by an N-terminal
segment called 5. The site of action of nuclear gene products
involved in expression (maturation of toxin from prepro-
toxin; SEC, KEX) and maintenance (MAK, SKI) of M-
dsRNA are also shown.
Plasmid Genotypes of S. cerevisiae Killers
The plasmid genotypes of the M-dsRNA variants in S.
cerevisiae killers are listed in Table 4. These are designated
[KIL-kfl, [KIL-k2], and [KIL-k3], respectively, for Ml-,
M2-, and M3-dsRNAs. Thus, a normal Kl killer strain
contains M1-dsRNA in ScV-M1 VLPs and has a [KIL-k1]
genotype and a (K1+ RI') killer phenotype. Strains carrying
no M-dsRNA are sensitives (K- R-) with a [KIL-o] geno-
type usually containing an L-dsRNA.
Because the M-dsRNAs are stably maintained and segre-
gated, mating of a sensitive, MAK+ [KIL-o] strain with a Kl
killer ([KIL-k1] genotype) produces a K1 + R1 + diploid
which, on sporulation, gives rise to 4:0 segregation of [KIL-
k1] killers (7, 127). Strains carrying a recessive mak nuclear
TABLE 3. dsRNA gene products
In vitro translation
In vivo products
dsRNA Product name In____ _ _ __ _ _ __ _ _
New Old
kd Precursor kd Mature
LlA LiA-P1 L-P1 88 VLlA-P1 (ScV-P1): capsid for VLPs
containing LlA and Ml-dsRNAs
L2A L2A-P1 L-P5 84 VL2A-P1: capsid for VLPs contain-
ing L2A and M-dsRNAs
LBC LBC-Pl L-P2 82 VLBc-P1 (ScV-P2): capsid for VLPs
containing LBC
LBC-P2 L-P3 78 Quite distinct peptide map from
LBC-Pl; comigrates with ScV-P3,
but identity not tested
Ml Ml-Pi 34.8 (preprotoxin) Protoxin 42 Toxin (9.5 [a] + 9.0 [la] kd)
M2 M2-P1 42 (preprotoxin) Protoxin NDa Toxin (18 kd)
M3 ND ND Protoxin ND Toxin (ND)
T, W ND ND ND ND
S3 S3-P1 8 (contains N None detectable None
terminus of
preprotoxin)
a ND, Not determined.
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dsRNA KILLER SYSTEM IN YEASTS 133
TABLE 4. Plasmid genotypes in S. cerevisiae killers
Killer and
Genotype Description M-dsRNA immunity
phenotype
[KIL-o] Lack known killer plasmids None K- R-
[KIL-k1] Normal Kl killer plasmid M, Kj+ RI+[KIL-k2] Normal K2 killer plasmid M2 K2+ R2+
[KIL-k3] Normal K3 killer plasmid M3 K3+ R3+
Mutants of
Kl killer
plasmid
[KIL-nl] Neutral M., K- Rj+[KIL-i1] Immunodeficient (suicidal) Mil KI+ Rlw[KIL-sl] Dominant suppressive (e.g., S K- R-
S3)
[KIL-sk1] Superkiller MI mutant K,++ Rj+[KIL-b1] Bypasses need for many M1 mutant K1+ Rj+
MAK gene products
[KIL-d1] Dependent on a diploid M1 mutant K1, Rj+
host
mutation (96, 150) are unable to maintain Ml-dsRNA and so
have a [KIL-o] phenotype. On mating to a [KIL-kl] strain, a
K1 + Rl + diploid is produced. Sporulation produces 2:2
segregation of mak [KIL-o] and MAK [KIL-k1] strains.
Recessive ski mutations (139) are nuclear suppressors of
mak mutations.
Plasmid Mutations in Ml-dsRNA
Few natural mutants of ScV-M1 have been identified (7,
24, 96, 99, 115, 126, 141, 143), possibly because of the high
copy number of its dsRNA genome. Vertical transmission of
this plasmid, by cytoplasmic exchange, is presumably ac-
companied by transfer of several copies. As a consequence,
segregation appears to be slow. Moreover, selective pres-
sure is constantly applied for sequences that are replicated
and expressed at an optimal level: too low a rate will result in
plasmid loss, whereas too high a rate would probably be
growth inhibitory or lethal. Ml-dsRNA plasmid mutations
have been defined which affect the expression of toxin
activity (neutral, [KIL-nl]), expression of immunity (suicid-
al, [KIL-i1]), and Ml-dsRNA replication (mak bypass, [KIL-
b], and diploid dependent, [KIL-d]) (Table 4). Their pre-
sumed locations are shown in Fig. 3. The [KIL-b] mutant is
discussed in "Nuclear Mutations Affecting M-dsRNA Main-
tenance," subsection "Superkiller (ski) Mutants and the
[KIL-b] Plasmid Mutant."
Neutral and suicidal mutants ([KIL-n1], [KIL-ij]). Neutral
mutants of M1-dsRNA (genotype [KIL-n1]) conferring a K-
R, + phenotype (Table 1) were observed early among natural
isolates (7). They have a defect in the toxin precursor gene
but not in the component responsible for immunity. Some
neutral strains, but by no means all, secrete an inactive
toxin, a cross-reactive protein (CRM) of apparently normal
size that is precipitated by antitoxin (see "Effect of Plasmid
Mutants on Toxin Maturation") (24). This presumably arises
from a missense mutation in the toxin structural gene (Fig.
3).
A superkiller mutant strain (T158c) with a K1 + + Rl +
phenotype (Table 1) was isolated (143) and later shown to
produce presumably normal quantities of a more stable toxin
(107) with a modified a component (Fig. 2).
Plasmid mutants have been isolated recently by growth of
a strain carrying the M1-dsRNA derived from T158c at 37°C,
causing gradual curing of the M1-dsRNA plasmid (24).
Ethylmethanesulfonate mutagenesis was applied at a stage
when a maximal fraction of cells contained a single Ml-
dsRNA molecule. Cells regenerated a normal copy number
when returned to 30°C and were screened for mutant killer
phenotypes. A diploid strain was used to avoid detection of
recessive nuclear mutations, and cytoplasmic inheritance of
the phenotype was confirmed by standard tests (7). A variety
of neutral (NLP) and "suicidal" (SLP) mutants were isolat-
ed.
The suicidal mutants ([KIL-i,] genotype) produce wild-
type quantities of normal toxin, but have a much reduced
immunity. These are thought to be defective in the immunity
determinant encoded by M1-dsRNA (Fig. 3). They still
survive, even when grown at pH 4.7 (the optimal pH for
toxin stability and activity), but unlike normal killers, which
survive high toxin concentrations, SLP mutants were killed
by concentrations only about 100-fold greater than those
required to kill sensitives derived by complete heat curing of
the killer plasmid from the parent cell line (24).
Suppressive mutants ([KIL-sll). Suppressive deletion mu-
tants of M1-dsRNA (genotype [KIL-sl]), called S-dsRNAs,
were reported in 1973 (126) and shown, by heteroduplex
analysis, to result from internal deletions (47, 70). Such
deleted plasmids confer neither toxin production nor immu-
nity, but on mating of a strain carrying a [KIL-sl] plasmid to
a [KIL-kl] strain, an unstable (Kl+ RI') diploid is produced.
It slowly segregates K- R- [KIL-sl1 suppressives. If the
unstable diploid is immediately sporulated, killer haploids
produced also segregate suppressives, 4:0. The mutant plas-
mid excludes the normal M1-dsRNA plasmid, giving sup-
pressive strains a dominant (K- R-) phenotype, much as
defective-interfering virus mutants interfere with replication
of wild-type viruses (63). However, unlike viral defective-
interfering particles, S-dsRNAs are not dependent on the
parent Ml-dsRNA; rather, both Ml- and S-dsRNAs are
defective satellites dependent on LA-dsRNA for encapsida-
tion, so that Ml can be completely eliminated and still allow
maintenance of an S-dsRNA. Since L-dsRNAs produce
capsid proteins essential for their own maintenance (see
"Role of L-dsRNA Species in VLP Capsid Production and
Ml-dsRNA Maintenance"), one might expect to find L
deletions which are the equivalent of classical viral defec-
tive-interfering particles, but which are not suppressives.
Such L deletions have not, however, been observed.
In a recent study (115), it was shown that suppression is
not a consequence of growth advantage of cells containing
the S-dsRNA, nor of a higher copy number of S- than Ml-
dsRNA. Rather, as anticipated, it seems to be due to
preferential replication of the S-dsRNA, possibly because of
competition for a limiting supply of some essential cellular
component. Three S-dsRNAs derived from the same M1-
dsRNA were found to fail to coexist stably. The most
suppressive was actually the largest of the three, so that
reduced genome length is not the cause of suppression.
Neutral mutants of unaltered size found coexisting with the
parental Ml-dsRNA in one unstable Kl killer strain (13)
were themselves suppressive (J. Sturgeon, K. A. Bostian,
and D. J. Tipper, Abstr. IX Int. Congr. Yeast Genet. Mol.
Biol., p. 102, 1978). This suggests that relatively subtle
mutations can lead to altered dsRNA replication efficiency.
This may explain the origin of natural isolates containing a
single mutant type of M-dsRNA, in spite of a presumed
initial excess of normal Ml-dsRNA.
The best-characterized S-dsRNA is S3, derived from the
mutant M1-dsRNA of superkiller strain T158c by an internal
1.2-kb deletion; 500- and 230-bp terminal fragments are left
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(47). Sequence analysis (D. J. Thiele, E. M. Hannig, and
M. J. Leibowitz, Virology, in press) has recently located
these fragments in M1-dsDRNA (Fig. 3). Two modified
forms of S3 segregated during replication: a dimeric mole-
cule (S1) and a form (S4) derived from S1 by a second small
deletion (47). Similar duplication and size variation have
been seen in other suppressives (115) and presumably arise
by some copy choice mechanism during transcription within
the VLPs.
Diploid-dependent mutant ([KIL-d1]). A [KIL-d] mutant
has been isolated in which the M1-dsRNA is only maintained
in a/a diploid cells (153). Maintenance of this dsRNA has
apparently become subject to MAT locus controls.
STRUCTURAL COMPARISONS OF KILLER dsRNAs
In spite of early reports to the contrary (reviewed in
reference 156), and in keeping with all of the genetic evi-
dence, recent hybridization experiments have failed to find
any homology between any killer dsRNA species and any
DNA genome in S. cerevisiae (8, 9, 57, 129). Probes used in
Southern blots of genomic DNA have included denatured
and fragmented dsRNAs, labeled with [y-32P]ATP and T4
polynucleotide kinase, representing all of the LlA-, LBC-,
and M1-dsRNAs (9) and nick-translated cDNA complemen-
tary to 50% of M1-dsRNA (9). Use of these probes and nick-
translated cDNAs complementary to segments at one termi-
nus of L1A-dsRNA (8) also demonstrate the lack of
detectable homology between M1 and any of the L-dsRNAs
and between LA and LBC-
Except for their single unpaired 3' bases, each dsRNA is a
perfect duplex. M1-dsRNA has an internal, asymmetrically
located, highly AU-rich bubble sequence of about 200 bp,
visible as a denatured region in electron micrographs (47)
and removed by treatment with RNase S1, leaving terminal
fragments of about 1,000 and 600 bp (Fig. 3) (145). No similar
region has been detected among L-dsRNAs. This difference
is believed to account for the fact that, whereas L-dsRNA
size is stable, M1-dsRNA size varies by up to 12% in
subclones of Kl killer strains (S. S. Sommer and R.
Wickner, personal communication). The transcriptase may
slip or skip while transcribing oligouridylic acid regions on
the negative strand in the bubble, leading to variation in
bubble size and insertion or deletion of oligoadenylic acid
[oligo(A)] sequences in the plus strand.
Each dsRNA has a relatively AU-rich terminus, the
source of a large RNase T1 oligonucleotide, and a relatively
guanine-cytosine-rich terminus (15). The AU-rich 5'-termi-
nal sequences reported for LIA, L2A, Ml, M2, and LBC-
dsRNAs are shown in Table 5.
Sequencing of dsRNAs from their 3' termini has provided
data for 100 to 250 bp of both ends of M1- and LlA-dsRNAs
(133-135; Thiele et al., in press). Earlier reports of sequence
heterogeneity in L-dsRNA (19) were, at least in part, due to
the presence of a mixture of LlA and LBc and probably also
to the presence in dsRNA preparations of multiple small
RNA species of about 100 bp (L. A. Weinstein and M. J.
Leibowitz, personal communication). These appear to be
specifically associated with the dsRNAs, but are not related
to the partial-length "pause products" synthesized by VLP
transcriptase (14) (see "Transcription and Replication of
Killer dsRNAs"). Some heterogeneity has been found in the
sequences of overlapping cDNAs, representing fragments of
a single L-dsRNA preparation (8; J. Bruenn; personal com-
munication), suggesting rapid sequence divergence. In con-
trast, very little divergence has been seen in comparing
sequences coding for toxin precursors in M1-dsRNAs from
normal and superkiller strains (see "Sequence of the Ml-Pl
Preprotoxin Gene" and "In Vivo Expression of Preprotoxin
cDNAs").
CELL CYCLE STUDIES OF dsRNA REPLICATION IN S.
CEREVISIAE
Replication of the killer dsRNAs probably occurs in two
distinct steps, as in reoviruses (122): a plus-strand transcript,
defined as encoding the known dsRNA gene products (VLP
capsid and toxin precursor), is produced in vitro by a VLP-
associated transcriptase (see "Transcription and Replication
of Killer dsRNAs") (14, 18, 59, 144). It must initiate at the
AU-rich dsRNA terminus (see Fig. 3). It presumably acts as
a template for a replicase which regenerates dsRNA by
synthesis of the minus strand. Encapsidation of the dsRNA
product would regenerate a VLP.
Both 5' ends of all L- and M-dsRNAs are pppG (20),
presumably the acceptor for polymerization of each strand.
All 3' ends are -CA-OH, with C pairing with pppG and the A
being unpaired (Fig. 3; Table 5) (19), with the exception of
LBC, in which both -CA-OH and -CG-OH 3' termini have
been found (44). This minor L-dsRNA species resembles the
Ustilago sp. dsRNAs in this respect (see "dsRNA Killer
System of U. maydis").
TABLE 5. Terminal sequences of dsRNAsa
dsRNA "Plus" genomic strand
LlA pppGAAAAAUUUUUAAAUUCAUAUAACUCCCCAUGCUAAGA..
. .UAGGGAAUUACCCAUAUGCA (OH)
L2A ppp GAAUAAUUUGAAUAUUC.... .... GCUUAUACACAUAUGCA (OH)
LBC ppp GAAUUUUUCCACUCGCACAC...
M1 pppGAAAAAUAAAGAAAUG ... .. .UAAUGCAACAGCAUAGAAGAAACACACAUC-A(OH)
(HO)-A-CUUUUUAUUUCUUUAC ... .... .GUGUAGppp
M2 pppGAAAAAUAAAGAG .... ... .UUUACCUAGCA(OH)
a In each case sequence is shown for the plus genomic strand. The complementary sequence of the minus genomic strand is shown only for M1, to illustrate the
3'-unpaired A(OH) residues. The AUGs followed by open reading frames are underlined in the M1 and LIA sequences.
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Several experiments demonstrate that ScV replication
occurs continuously throughout the yeast cell cycle (100),
although Zakian et al. report a pause in ScV-L replication
during the S phase (171). Our own unpublished data indicate
continuous VLP capsid, ScV-L, and ScV-Ml synthesis in
pulse-labeled cells, in balanced growth, fractionated on
sucrose gradients. The stability of ScV maintenance and the
relative stability but wide strain variation in ScV copy
number remain unexplained. In any given strain, nutrient
conditions can cause ScV-L copy number to vary as much as
threefold; higher numbers are found in ethanol-grown cells
than in glucose-grown cells (105), and starvation for nitrogen
source causes extensive degradation of preexisting L-
dsRNA (33). The return of ScV-LlA and ScV-Ml to a normal
copy number at 25 to 30°C, after partial heat curing by
growth at 37 to 39°C (24), suggests feedback regulation of
dsRNA copy number or recovery of some temperature-
sensitive, rate-limiting step in VLP replication.
It has recently been shown (R. A. Sclafani and W. Fang-
man, personal communication) that full-length I and m
transcripts of the killer L- and M-dsRNAs (see "Transcrip-
tion and Replication of Killer dsRNAs") accumulate 50- to
100-fold in cells blocked at the Gl/S cell cycle boundary by
the use of a-factor and cdc7 blocks. Entry into S after relief
of the block leads to reduction in 1, possibly due to replica-
tion, but further increase in m. Replication of dsRNA thus
appears to require some cellular components involved in the
initiation of DNA synthesis. These must be constitutively
present to allow dsRNA synthesis in Gl. They are either
inactivated or selectively occupied by DNA synthesis on
entry into S phase.
TRANSCRIPTION AND REPLICATION OF KILLER
dsRNAs
Isolated intact VLPs containing both L- and M1-dsRNAs
also contain a transcriptase activity which, in the presence of
nucleotide triphosphates, produces full-length, non-comple-
mentary, single-stranded transcripts having messenger activ-
ity for the known dsRNA gene products (14, 15, 18, 59, 144,
146). The mechanism of transcription appears to be conserv-
ative (100; Sclafani and Fangman, Mol. Cell. Biol., in press),
with extrusion of the newly synthesized plus strand. Howev-
er, this is difficult to establish with certainty.
The 4.7-kb in vitro, single-stranded transcript from ScV-
L1A encodes LlA-P1 capsid (Table 3), whereas the 1.9-kb m
transcript from ScV-M1 encodes Ml-Pl, the preprotoxin.
Both 5' and 3' sequencing of the transcript from VLPs
containing Ml-dsRNA have been performed (54). The tran-
script is a faithful copy of the genomic dsRNA, initiating and
terminating at the ends, without polyadenylation. Addition
of an extra 3'-terminal purine occurs in vitro, 53% A and
38% G, although only A has been identified in vivo (19).
The strands of Ml- and LlA-dsRNAs have been separated,
and the minus strands have been identified by hybridization
with the in vitro plus-strand transcripts (133, 134). Determi-
nation of their 3' sequences confirms the 5' sequences of the
in vitro transcripts, which initiate at the AU-rich terminus of
both LlA- and M1-dsRNAs (Table 5). This is also the natural
terminus present in the larger (1 kb) S1 nuclease fragment of
Ml (145), demonstrating that the M1-Pl gene in this fragment
is transcribed toward the bubble (Fig. 3).
Full-length, plus-stranded transcripts of the killer dsRNAs
are also found in vivo (9), together with unique partial-length
transcripts. These partial-length transcripts, la (2.3 kb) de-
rived from LlA and ma (1.2 kb) derived from Ml, share the
mRNA activities of their full-length counterparts (9). Hy-
bridization to the separated plus and minus strands of M1-
dsRNA confirms the positive polarity of both full-length and
partial transcripts (54). It is not known whether any of these
transcripts are capped. The ratios of these dsRNAs and their
transcripts in killer strain K12-1 are shown in Table 6.
Transcripts of the LBC species, present as a minor L
component in strain K12-1, were not investigated (9).
The existence of both full-length and partial-length plus-
strand transcripts for both dsRNA species investigated sug-
gests differential function for these two species. It seems
plausible that the full-length transcripts are intermediates in
a reovirus-like replication mechanism (122), whereas the
partial-length transcripts, which are just long enough to
encode the preprotoxin and capsid gene products, are re-
sponsible for expression of the dsRNA genes in vivo.
Perhaps secondary structure or binding of capsid or other
proteins masks the mRNA activities of m and in vivo,
avoiding the potential collision of ribosomes and replication
machinery converging from opposite ends of a single plus
strand. Alternatively, the partial-length mRNAs may not
express all of the dsRNA genes: if secondary structure or
bound proteins mask the known initiator AUG in the full-
length transcripts, they might serve as messengers for differ-
ent (unidentified) gene products derived from downstream
initiation or ribosome binding sites, absent or inaccessible in
the partial-length transcripts. The VLP-associated transcrip-
tase and the immunity determinant are candidates for such
unidentified products. However, immunity probably forms
part of the preprotoxin (see "In Vivo Expression of Prepro-
toxin cDNAs").
The AU-rich 3' termini of LlA-, L2A-, M1-, and M2-
dsRNAs (Table 5) share a common eight-base sequence,
AUU(U/A)UUCA-OH, postulated to be the transcriptase
recognition site (15). The sequence in LBC, AAAAAUUC(A/
G)-OH, differs considerably (Table 5). Since the M1-Pl gene
initiates only 6 bp upstream of this site (see below), the 1.2-
kb ma transcript must initiate at the same terminus as the
full-length transcript. It probably terminates within the AU-
rich bubble sequence of M1, just beyond the end of the M1-
P1 gene (Fig. 3). It is not known whether ma is a product of
premature transcription termination or of cleavage of m.
Cleavage, as in the processing of some mitochondrial tran-
scripts, might be dependent on translation initiation.
Both m and ma bind tightly to polyuridylic acid [poly(U)]-
Sepharose, suggesting polyadenylation (9). However, it has
recently been shown (54) that the separated plus strand of
Ml-dsRNA and the in vitro synthesized m plus strand,
neither of which bears a 3'-terminal polyadenylic acid
TABLE 6. Relative molar concentrations of dsRNAs and their
transcripts in K1 killer strain K12-1a
Species kb Relative Molecules
concn per cell
LlA-dsRNA 4.7 100 30
LBc-dsRNA 4.7 10 3
l transcript of LlA 4.7 2 0.6
la transcript of LlA 2.3 9 3
Ml-dsRNA 1.9 69 (100) 21
m transcript of M1 1.9 9 (14) 3
ma transcript of M1 1.2 11 (17) 3
a LIA-dsRNA represents 0.03% of the total RNA in these cells, giving a
copy number of about 30. The LBC relative concentration is estimated from
stained gels. All other relative concentrations are derived from Northern blots
(9).
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136 TIPPER AND BOSTIAN
[poly(A)] sequence, both bind to oligodeoxythymidylic acid
[oligo(dT)]-cellulose and have precisely the same thermal
elution properties on poly(U)-Sepharose as the m and ma in
vivo transcripts (9). In contrast, the minus M1 genomic
strand and both strands of S3 dsRNA (deleted for the
bubble; Fig. 3) fail to bind to oligo(dT)-cellulose. Binding is,
therefore, due to the presence of oligo(A) regions in the Ml
plus strand, almost certainly within the AU-rich bubble
sequence. Thus, the in vivo ma transcript probably termi-
nates after this A-rich bubble sequence, which may perform
the functions usually provided by the post-transcriptionally
added 3Y-oligo(A) regions of yeast nuclear mRNA tran-
scripts. The genomic RNAs of the single-stranded poliovi-
ruses and alphaviruses both possess long 3'-terminal poly(A)
tracts (118).
The site of the LIA-Pl capsid gene in L1A is not known.
However, an open reading frame does start with AUG at
bases 30 to 32, continuing through the known 113-bp se-
quence (133). Since translation from yeast transcripts nor-
mally initiates at the first AUG, this may be the start of the
capsid gene unless its context (79) (it is preceded by CCC,
not a favored sequence) makes it considerably less favorable
than the next downstream AUG (F. Sherman, personal
communication). No other AUG exists within the 113-bp
sequence and, in common with Ml- and reovirus dsRNAs
(36), it seems likely that translation initiates close to the
terminal transcription initiation site, probably at this first
AUG. If so, then la, which is just long enough to encode LlA-
P1, probably resembles ma in being a 5' fragment of the full-
length transcript (9). It should terminate halfway through
LiA. The function of the 3'-terminal 2.5 kb of L-dsRNA is
unknown. The stability of L-dsRNA size suggests an essen-
tial structural or genetic role.
It has been noted (82) that the m plus strand has a plausible
ribosome binding site just upstream of the M1-Pl initiation
AUG codon (Fig. 3) capable of significant base pairing to
yeast 16S and 5.8S rRNAs. This is believed to have little if
any significance for eucaryotic nuclear transcripts where
interactions with the cap and cap binding protein may be of
primary importance in translation initiation. It might be
significant for the cytoplasmic dsRNA transcripts, if they are
uncapped; however, this is only speculation at this point.
Moreover, the LlA sequence lacks an obvious ribosome
binding site (133). Although this might explain why dena-
tured Ml-dsRNA is a far better in vitro messenger than
denatured LlA-dsRNA (the dsRNAs are uncapped), this
may, alternatively, reflect the different contexts of the
initiator AUG sequences. Both the short 5' sequence in M
preceding the initiation AUG and that in the LlA plus strand
(133) are A rich and G poor, characteristics of many yeast
mRNAs (60).
The full-length in vivo transcript 1, but not la, binds to
poly(U)-Sepharose (9). No AU-rich sequence is known to
exist in LlA, and Hannig et al. (54) found no binding of the
LlA in vitro transcript to oligo(dT)-cellulose, so that 1, the in
vivo equivalent, may be polyadenylated. However, an oli-
go(dT)-primed, 4.3-kb cDNA has been made from denatured
L-dsRNA (16). Also, Haylock and Bevan (56) failed to find
binding of the full-length I in vivo transcript to oligo(dT)-
cellulose. Possibly differential binding to poly(U)-Sepha-
rose, which requires shorter oligo(A) stretches than binding
to oligo(dT)-cellulose, indicates the presence of relatively
short oligo(A) stretches within the LIA PlUS strand, perhaps
terminating la and the LlA-P1 gene. It was suggested (9) that
post-transcriptional polyadenylation may be common to the
presumptive in vivo replication intermediates m and 1 and
that subsequent removal of poly(A) might leave the terminal
unpaired -A-OH on the dsRNAs. However, there is no
precedent for such a mechanism. Poly(A) addition now
seems unlikely, and the existence of terminal -CG-OH on a
major fraction of LBC molecules (44) argues against a
poly(A) origin for terminal -CA-OH. Perhaps post-transcrip-
tional addition of a single 3'-terminal A or G occurs as in E.
coli SP, RNA phage (2).
Yeast cells appear to lack significant pools of dsRNA or
ScV-P1 capsid except in VLPs (13). Production of either
may, therefore, limit the rate ofVLP replication. Strain K12-
1 contains only about 30 molecules of L- and 20 of Ml-
dsRNA per cell (Table 6). The copy numbers of full-length
transcripts, averaging about 0.6 of 1 and 3 ofm per cell in this
strain (Table 6), should depend on ScV copy number,
transcription rate, transcript stability, and the rate of initia-
tion of dsRNA replication on these transcripts. The exis-
tence of these small pools of 1 and m suggests either that
these transcripts are sequestered in polysomes or that initia-
tion of negative-strand synthesis is rate limiting for dsRNA
replication.
Replication of dsRNAs on their plus-strand transcripts
initiates at their C-rich 3' termini. There is little sequence
homology among dsRNAs at this site (Table 5), and Brennan
et al. (15) have suggested that a short 3' stem-and-loop
structure, present just before a terminal AUGCA-OH se-
quence, may be the replicase recognition site. In plant viral
genomic RNAs, such as alfalfa mosaic virus, such a struc-
ture serves to bind capsid as a necessary part of a replication
complex (78). If this is also true of the ScV-dsRNAs, then, as
suggested by Brennan et al. (15), capsid production, poten-
tially controlled by la concentration, could control initiation
of dsRNA replication as well as encapsidation. It seems
likely that capsid binding to nascent dsRNA and encapsida-
tion would at least accompany replication, protecting
dsRNA from RNase activity and regenerating a VLP. A
dsRNA-specific nuclease has recently been identified in
yeasts (D. J. Mead, and S. G. Oliver, Proc. XI Int. Conf.
Yeast Genet. Mol. Biol., p. 46, 1982). Thus, the rate of
production of the la partial transcript, and the efficiency of its
interaction with ribosomes, may ultimately control the ScV
copy number. For ScV-LA, copy number varies from 30 to
50, in strains such as K12-1, to several thousand in the
atypical sensitive strain S7 (17). As suggested by Field et al.
(44), competition for a limited capsid supply among different
dsRNA species might account for the reduction in copy
numbers seen in mixtures of compatible species such as LlA
and Ml (S. G. Ball, C. Tirtiaux, and R. B. Wickner, Genet-
ics, in press) as well as exclusion among apparently incom-
patible species such as Ml and its suppressive derivatives
(see "Summary of Phenotypes . . .," subsection "Plasmid
Mutations in Ml-dsRNA") and Ml and M2 (see "[HOK],
[EXL], and [NEX] . . .," subsection "Exclusion of M2- by
M1-dsRNA"). No in vitro model of second-strand synthesis
currently exists for testing the role of capsid in this process.
ROLE OF L-dsRNA SPECIES IN VLP CAPSID
PRODUCTION AND M1-dsRNA MAINTENANCE
All Kl, K2, or K3 killers contain at least one species of L-
dsRNA (about 4.7 kb; Table 2) as well as the M-dsRNA
killer determinant. This is also true of cells maintaining the
various mutant forms of Ml-dsRNA. In fact, almost all S.
cerevisiae isolates contain a form of ScV-L, even though a
majority are sensitives lacking M-dsRNA.
The first successful attempt at using in vitro translation of
denatured dsRNA to determine gene function demonstrated
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dsRNA KILLER SYSTEM IN YEASTS 137
that the (major) L-dsRNA of sensitive strain 3/Al codes for
the capsid protein, ScV-P1 (88 kd), which comprises at least
95% of the VLP protein in this strain (62). Antisera raised
against ScV-L were shown to precipitate both ScV-L and
ScV-M1 (55), and it was later shown, in the K1 killer strain
2-1, that ScV-Pl capsid comprised at least 95% of the protein
in both separated ScV-L and ScV-Ml VLPs (13). Minor
proteins of unknown function, called ScV-P2 (82 kd) and
ScV-P3 (78 kd), were consistently found in VLPs of strain 3/
Al (62) and in both ScV-L and ScV-M, in strain 2-1 (13). It
was proposed that encapsidation is essential for dsRNA
maintenance and that M1 is a satellite "mycovirus" depen-
dent on L as a source of VLP capsid (62). Reciprocal
dependence of L on M1 clearly does not exist, so that M1 and
L are not parts of a single mycovirus system.
Nomenclature and Function of the Various L-dsRNA Species
It has now been shown that most S. cerevisiae strains
contain at least two unrelated L-dsRNA species, as first
suggested by Sommer and Wickner (128). The M-dsRNA
killer plasmids are dependent satellites of one L-dsRNA
class, whereas a second L-dsRNA class is unrelated to the
first or to M. A third class ofdsRNA molecules, called T and
W, has recently been described (see "T-, W-, and XL-
dsRNAs") and others may exist. Laboratory yeast strains
are known which have most combinations of these three
potentially independent ScV types, including abscence of
any detectable dsRNA. Their role, if any, in cell metabolism
is, therefore, obscure. This is discussed further below ("T-,
W-, and XL-dsRNAs"), following descriptions of the struc-
tural relatedness, gene contents, dependence on nuclear
genes, and relationship to M-dsRNA maintenance of the
different L-dsRNA species.
The L-dsRNAs found in Kl killers and related strains
were called L1 and La by Field et al. (44), LA, LB, and Lc by
Sommer and Wickner (129), and "L2" and "L1" by El
Sherbeini et al. (41) (L1 = LA = "L2"; La = LB or Lc =
"'L1"). "'L1" in native form migrates slightly more slowly
than "L2" on agarose gels (41). Whereas this difference has
been seen reproducibly, it is only obvious after application
of a rapid isolation procedure (41) and might reflect a
modification specific to "'L1" (e.g., bound protein) rather
than true size difference. In general, all recognized L-
dsRNAs are of approximately the same size (estimated at 4.5
to 5.0 kb). Field et al. (44) called the major L species in K2
killers L2, since they found it to differ from L1 in terminal
sequence (15) (Table 5), and noted that their K2 killers also
contained La.
Nomenclature in the L-dsRNAs needs clarification. Be-
cause numbers have already been adopted to designate the
Ki, K2, etc., killer phenotypes, any numbers associated
with L-dsRNAs should reflect a relationship to the M1-, M2
(etc.)-dsRNA killer determinants. The LA, LBc nomencla-
ture of Sommer and Wickner (129), adopted here, seems the
most useful primary distinguishing system. LB and Lc have
been distinguished in four strains (129) and appear to be
closely related. The similar species found in other strains
will be called LBC. Variants of LA are all competent, to a
variable extent, for the maintenance of Ml- and M2-dsRNAs,
whereas variants of LBC are not. Evidence is accumulating
to indicate that this reflects the ability of capsid encoded by
LA to encapsidate M-dsRNA in VLPs. Capsid encoded by
LBC is known only to encapsidate itself (see below).
Although the known variation in LBC properties is small, a
broad spectrum of LA phenotypes is already known. The
variants found in naturally isolated Ki killer strains share
only partial sequence homology with those of K2 strains
studied and encode distinctly different capsid proteins. We
shall call the species isolated from killer strains LiA and L2A
to denote the associated killer type, after Bruenn (44),
although it appears probable that they are quite similar in
their abilities to maintain M1- and M2-dsRNAs. LA subspe-
cies vary in their ability to maintain Ml and M2 dsRNAs in
different nuclear and cytoplasmic genetic backgrounds
{SKI+ or ski-, etc.; see next section, subsection "Super-
killer (ski) Mutants and the [KIL-b] Plasmid Mutant"}. The
associated [HOK], [NEX], and [EXL] phenotypes (see
below) have been denoted LA-HN, LA-E, etc. (129). We shall
use this nomenclature where natural association with M-
dsRNA is not known, as for LA-E from the sensitive strain
AN33 (129). The LA type found in all naturally isolated Kl
killers analyzed is LA-HN, which we shall call L1A-HN-
The potentially independent VLP systems which include
these different L-dsRNAs are called ScV-LA (including ScV-
L1A and ScV-L2A) and ScV-LBC (Table 3). ScV-LBC is
apparently found in both Ki and K2 killers (44; our unpub-
lished data) (Table 2), so it must be compatible with LIA plus
M1- or L2A plus M2-dsRNAs.
Comparison of Sequences of L-dsRNAs
Apart from the apparent slight difference in size between
LBc and LA detected on agarose gels (41), L-dsRNAs appear
to be remarkably constant in size even when isolated from S.
cerevisiae strains of diverse origin. It has recently been
shown (133) that the separated, single strands of LIA are
easily resolved from those of LB or Lc on native 5%
acrylamide gels, presumably as a consequence of different
secondary structures. The strands of LB, however, were not
clearly resolved from those of Lc by this procedure.
In most Kl killers studied, LlA comprises 90 to 95% of the
L-dsRNA and LBC, only 5 to 10%. However, occasional Ki
strains are found in which LBC is a considerably larger
fraction of the total. Such strains (e.g., K23) are inefficient
killers with low LlA and Ml content (our unpublished data).
Three killer strains (K7, K22, and K12) and one sensitive
strain (S7) are now known to contain only LlA (41, 129; our
unpublished data). These strains have a higher content of
LA-dsRNA than strains also containing LBC. A reciprocal
relationship between LA and LBC copy number is suggested.
Appropriate isogenic strains must be studied to test this
possibility. A decrease in LA content probably also reduces
the Ml content of Kl killers, because of the dependency of
Ml on LA. Conversely, nuclear ski mutations leading to a
selectively higher Ml content also depress LA copy number
(see "Effect of mak and ski Mutations on L-dsRNA Mainte-
nance").
The K2 killer strain Y110 contains only L2A and M2 (our
unpublished data), whereas K2 killer strain 482 also contains
LBC. Thus, LBC seems to play no necessary role in mainte-
nance of Ml-, M2-, LlA-, or L2A-dsRNAs. Formally, LBC
belongs to a separate mycovirus, ScV-LBc, whose interac-
tion with ScV-LA and ScV-M species is largely character-
ized by indifference.
Terminal sequencing of these dsRNAs is progressing (15,
19, 44, 133) (Table 5) and shows little conservation beyond
the first nine bases. Most of the available information on
internal sequence relatedness among dsRNAs depends on
hybridization analyses and T1 nucleotide maps. These nucle-
otide maps show no relationship between LlA and LB or Lc
and only slight homology between LB and Lc (129). Liquid
hybridization also shows LlA to be unrelated to LB or Lc;
however, LB and Lc are about 50% related by such an assay
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138 TIPPER AND BOSTIAN
(129). It is calculated that as little as 12% random sequence
modification is required to give totally different T1 finger-
prints (129). "Northern" blot analyses confirm these find-
ings. Portions of LlA (200 to 400 bp) have been cloned as
cDNAs, using short in vitro transcription products derived
from the 5' terminus as template (8). A cDNA probe
representing 325 bp close to the AU-rich terminus of LlA and
a second probe derived from a region near this terminus, but
separated from it by at least 585 bp, failed to react with LBC
(8). Use of labeled fragments representing all of LIA and LBC
as probes also confirms the lack of detectable homology
between LlA and LB or Lc, and between LBC and LlA or
L2A, and confirms the marked similarity of LB and Lc (137;
our unpublished data). The LlA probe cross-hybridized
about 20 to 30% with L2A (our unpublished data). The
terminal cDNA probe derived from LIA also reacted moder-
ately strongly with L2A, whereas the internal cDNA probe
failed to react (8). Only limited regions of LlA and L2A may,
therefore, be sufficiently homologous in sequence to cross-
hybridize. LlA and L2A are distinctly less related than LB is
to Lc.
Capsid Proteins Encoded by the Various L-dsRNAs
The gene products presumed or proven to be encoded by
various L-dsRNAs are listed in Table 3. Translation of
denatured LlA produces LlA-Pi, the previously identified
88-kd major ScV-P1 capsid in Kl killers (62), which is
capable of encapsidating M1-dsRNA (13). This is now called
VL1A-P1 (Table 3).
Translation of L2A produces L2A-P1 (84 kd; Table 3),
identical to the VL2A-P1 major capsid protein in strain 482
killer VLPs. L2A-P1 is quite distinct from L1A-P1 in its
peptide map (34; M. El Sherbeini et al., submitted for
publication).
Translation of denatured LB, Lc, or LBC produces LBC-
P1, an 82-kd polypeptide that has been shown, by peptide
mapping (34), to be identical to the single capsid protein in
VLPs containing LBC (VLBC-Pl, Table 3) (El Sherbeini et
al., submitted for publication). VLP capsid proteins from
strains containing only LBC were previously reported (129)
to comprise a mixture of components smaller than LlA-Pl.
However, LBC-P1 is extremely sensitive to proteolysis and
the lower-molecular-weight species may be degradation
products. Peptide maps fail to distinguish between the 82-kd
capsids from VLPs isolated from strains containing only LB,
only Lc, or LBc-dsRNAs. However, these capsids are
clearly different from those of VLPs containing LIA- and
L2A-dsRNAs (El Sherbeini et al., submitted for publication).
LBC-Pl was previously called L-P2, a major translation
product of denatured L-dsRNA from strains such as K12-1
which contain both L1A and LBC. Even though LBC is only 5
to 10% of the dsRNA in these strains, it is apparently a much
more efficient in vitro messenger and L-P2 (LBC-P1) is often
the predominant translation product. VLBC-Pl comigrates
with ScV-P2, first identified as a minor VLP component in
strain 3/Al, a strain containing LBC (62; our unpublished
data). However, ScV-P2 is also seen in strain 2-1, which
contains only LlA (our unpublished data), where its source is
unknown. The source of ScV-P3, seen in VLPs of both
strains 3/Al (62) and 2-1 (13), is also unknown. It comigrates
with LBC-P2 (Table 3), a translation product of LBC which is
distinctly different in peptide map from LBC-P1, but which
has no identified in vivo equivalent.
VLPs from strain K23, a Kl strain having relatively high
LBC levels, can be separated into a lighter ScV-M1 peak and
a heavier ScV-L peak in which ScV-LlA and ScV-LBc are
partially resolved. The ScV-M1 peak contained only VLlA-
P1, confirming the role of this capsid in Ml maintenance (13)
and consistent with the inability of VLBC-P1 to perform this
function. The VLlA-P1 and VLBC-Pl peaks in the ScV-L
peak coincided with the LlA- and LBC-dsRNA peaks, re-
spectively, suggesting that each L-dsRNA is encapsidated
only by its homologous capsid protein (El Sherbeini et al.,
submitted for publication). This has been clearly demon-
strated by Thiele et al. (133), who fractionated the VLPs of
strain NK3 [KIL-sl]. Heavy VLPs contained LIA- and S3-
dsRNAs (not fractionated) and VL1A-P1. A very light VLP
peak contained LBC and was found to contain three smaller
proteins, essentially as previously reported for LBC VLPs by
Sommer and Wickner (129). It seems likely that the low
density of the VLPs containing LBc-dsRNA, which were
found near the top of the gradient, was due to damage, for
which the protease sensitivity of LBC-Pl may have been
responsible.
In a similar experiment, it was shown that the dsRNA
transcriptase activity in the light VLP peak from a Kl killer
was much more heat labile than in the heavier peak (87). On
the assumption that this peak contained ScV-M1, this result
was postulated to explain the heat curability of ScV-M1.
However, these VLPs were almost certainly damaged forms
of ScV-LBC-
NUCLEAR MUTATIONS AFFECTING M-dsRNA
MAINTENANCE
Maintenance of Killer (mak) Genes: the KRBI Mutation
By screening Kl killer strains for (K- R-) segregants,
easily scored by replicating onto a lawn of sensitive cells
(Fig. 1), mutants in 30 nuclear loci (spe2, spelO, pet18,
maki, mak3-28) that cause loss of M1-dsRNA have been
identified (96, 139a, 150, 155, 162, 165). This screen will also
include kex mutants (see "Structure of the M1-dsRNA
Preprotoxin Gene and Steps in Toxin Maturation"), but
unlike mak mutants, kex mutants retain immunity, also
easily scored as in Fig. 1. Many mak mutants are marked by
a single allele, and it is estimated (156) that 100 such loci may
exist, a surprisingly high number. They are not clustered and
have been mapped to 15 of the 16 known yeast chromosomes
(165).
Because the presence of LA or LBC confers no obvious
phenotype on a sensitive S. cerevisiae strain lacking M-
dsRNA, their loss cannot be so easily monitored. However,
the dependence of M on LA-dsRNA allows detection, in
killers, of mutants required by both M and LA or whose
primary defect is in LA-dsRNA maintenance. Three of the
killer maintenance mutants (petl8, mak3, and makl0) have
recently been found to fall into this category (see next
section). None of the MAK genes is required for LBC or W
(see "T-, W-, and XL-dsRNAs").
Although conditional mutants were not deliberately
sought, several mak mutants result in slow growth (spe2,
petl8, mak13,15,17,20,22,27), whereas maki, mak16,
mak3O, and pet18 alleles are temperature sensitive for
growth and mak6 is cold sensitive (156, 165). MAK6 has
recently been identified with a previously known locus,
LTS5, causing growth to be cold sensitive at 8°C (114). A few
conditional (temperature-sensitive) mak mutants were found
in a deliberate search (50). Thus, M1-dsRNA maintenance is
critically dependent on the function of a number of nuclear
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TABLE 7. Summary of biochemical properties and known genetic requirements of S. cerevisiae dsRNA typesa
dsRNA [HOK], Size Hybridizes Encodes PET18 MAKI,8 SPEIO MKTJ,2 CLO+ Temp
species etc. (kb) to: MAK3,10 SPE2 MAK27
LIA LA-HN 4.7 LlA(++) Capsid + ts
L2A LA-H 4.7 L1A(+) Capsid + ts
LA-HE 4.7 NT Capsid + ts
LA-E 4.7 NT Capsid + + ts
LBC 4.7 LBC Capsid +
T 2.7 T ? TI
W 2.25 W ? TI
M1 1.9 Ml Preprotoxin + + + ts
M2 1.7 NT Preprotoxin + + + + ts
a Characteristics listed include associated [HOK], [NEX], and [EXL] phenotypes (see text, "[HOK], [EXL], and [NEXI: variations in ability of LA to maintain
M-dsRNAs"), indicated by HN and E suffixes, and positive hybridization interactions. Only those probes listed have been tested, each against all species listed,
indicating also the nonhomology between Ml, LlA, LBC, T, and W. Nuclear genes required for maintenance in SKI+ hosts are indicated by + (described in text,
"Nuclear Mutations affecting M-dsRNA Maintenance"; "Effects of mak and ski Mutations on L-dsRNA Maintenance"; "T-, W-, and XL-ds-RNAs").
"Temp" indicates temperature sensitivity of maintenance: ts, loss (curing) at high temperature; TI, enhancement at high temperature. NT, Not tested.
genes whose products are important or essential for cell
growth.
PET18 is required for M1-dsRNA maintenance and also
for maintenance of mitochondrial DNA (84); other pet
mutations tested (a large number are now known) do not lead
to loss of M-dsRNA.
Genes of known function required for Ml maintenance
include SPE2, which encodes adenosylmethionine decar-
boxylase, required for spermine and spermidine biosynthesis
(35), and SPEIO, which encodes ornithine decarboxylase,
required for synthesis of putrescine (139a). Cells grow
slowly (but fail to undergo meiosis or to sporulate) in
complete absence of SPE2 function. Both spe2 and spelO
mutants lose Ml-dsRNA. No other dsRNAs are affected,
except for the loss of LA-E, an unusual LA variant (see
"[HOK], [EXLJ, and [NEX]. . .," subsection "[EXL], LA-
E, and LA-HE"), in spelO mutants (139a). This variant,
unlike all other L-dsRNAs, also requires MAK27 (159). The
physical characteristics of the different S. cerevisiae
dsRNAs and their differential chromosomal gene require-
ments are listed in Table 7
MAK8 is identical to TCMI (166), the gene for trichoder-
min resistance, encoding ribosomal protein L3. Some func-
tion of this protein is apparently more critical for Ml-dsRNA
maintenance than for growth. This function could involve
translation, as part of the ribosome, or might, for example,
involve direct interaction of protein L3 with Ml-dsRNA or
its transcripts, just as the E. coli translational factors Tu, Ts,
and S1 are involved in replication of Q,B RNA phage (2).
MAKI has recently been identified with the gene for yeast
topoisomerase-1 (136). Screening of extracts of temperature-
sensitive mutants identified a mutant with a topoisomerase-1
(temperature-sensitive) defect. This was found to be allelic
with makl-J, which has less than 1% wild-type topoisomer-
ase-1 activity by this in vitro assay, a surprising result.
Loss of functional mitochondrial DNA bypasses the re-
quirement for MAKIO for maintenance of Ml-dsRNA; anti-
biotic-induced respiratory deficiency does not (154). A domi-
nant nuclear mutation in the KRBJ locus, isolated as a
suppressor of mak7, also bypasses petl8 (164) (Table 8), but
not several other mak mutations. Although loss of Ml-
dsRNA is prevented in petl8 KRBJ strains, mitochondrial
DNA loss is not prevented. The interplay between these
nuclear loci, mitochondrial DNA, and Ml-dsRNA mainte-
nance is not understood. KRBJ is centromere linked, but is
not located on any of the 16 known yeast chromosomes. It
thus defines a new chromosome, XVII (161).
Superkiller (ski) Mutants and the [KIL-b] Plasmid Mutant
The same plate test for killer zone size (Fig. 1) which
allows detection of (K- R-) mak mutants derived from (K+
R') killers also allows identification of "superkiller" (K"+
R+) strains in which the zone of killing is larger than normal.
Such strains fall into several categories, as follows:
(i) loss of toxin cell wall receptor (krel,2 mutants; see
"Mode of Action of Killer Toxin") resulting in escape of a
larger fraction of toxin produced into the medium (32);
(ii) a skiS mutation resulting in loss of a toxin-degrading
exocellular protease and increased toxin accumulation (see
"Mode of Action of Killer Toxin"; 31);
(iii) a [KIL-skl] mutation in MI-dsRNA, as in strain
T158c, resulting in production of a more stable toxin,
presumably less sensitive to the ski5 gene product;
(iv) a [KIL-bl] plasmid mutation, presumed but not prov-
en to reside in MI-dsRNA, which results in an increased M1-
dsRNA copy number (139; R. B. Wickner, personal commu-
nication) and is presumably responsible for increased toxin
production (common in laboratory yeast strains);
(v) mutations in nuclear ski2,3,4,6,7,8 loci which also
increase the Ml-dsRNA copy number (and also that of L-
dsRNAs; see next section) (114, 139); and
(vi) a skil mutation, which increases toxin production
without an effect on Ml-dsRNA copy number. Unlike other
ski mutations, skil fails to suppress mkt ("[HOK], [EXL],
and [NEX] ...," subsection "[NEX], LA-HN, and
mktl,2").
The skil,2,3,4 mutants were first identified by this super-
killer phenotype and later found to suppress certain mak
mutations (139). The skiS,6,7,8 mutants were later discov-
ered by a second phenotype, suppression of mkt [see section
cited in (iv) above]. Their effects on mak mutations have not
yet been described. The [KIL-bl] plasmid mutation also
"bypasses" a requirement for certain intact MAK genes
TABLE 8. Classification of MAK and ski mutationsa
Suppressed by:
mak group Genes
skil ski2,3,4 [KIL-b] KRBI
MI makl6
MIl mak3,10 pet18 +
MIII makl2,21,26 + +
MIV makl,4,6,7,11 spe2 + + +
mak7 petl8 + + + +
a ski6,7,8 (see text) have not yet been fitted into this scheme.
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(139); the classification of this plasmid mutation, KRBJ, and
of makl4 mutations with respect to suppression of mak
phenotype is shown in Table 8. None suppress makl6; the
three genes required for LlA maintenance are suppressed
only by skil; ski2,3,4 suppress all of those suppressed by
[KIL-bl], plus makl2,21,26 (160). All ski mutants (except
ski5), suppress the other mak mutations.
In certain killers, a cytoplasmically inheritable phenotype
is found in which Ml-dsRNA maintenance is dependent on a
ski mutation. This was originally attributed to a variant in the
M1-dsRNA itself and given the name [KIL-sdl] (138). It is
now known to be due to the presence of an L-dsRNA
variant, LA-E, in these strains. LA-E is unable to maintain
Ml-dsRNA in a SKI' background, but is competent in ski-
(see "[HOK], [EXL], and [NEX]: Variations in Ability of
LA to Maintain M-dsRNAs").
Since mak mutations include the topoisomerase, petl8,
tcml, and spe2 mutations, in genes of widely different
function, speculation on common functional interactions
between the products of MAK and SKI genes seems to be
premature. However, the growth-retarding or conditional
nature of many of these mutations and the complex pattern
of nuclear-dsRNA plasmid interactions implied by this ge-
netic analysis do indicate the profundity of the integration of
maintenance of M1-dsRNA, and to a lesser extent of LA-
dsRNA, with essential cellular maintenance machineries.
Some of this complexity might derive from exploitation by
the dsRNAs of cell regulatory systems involving direct
interaction of multiple regulatory gene products, in the type
of regulatory protein complex postulated to govern expres-
sion of the yeast acid phosphatase genes (137). A likely focus
of this regulation is initiation of dsRNA replication by
second-strand synthesis on a primary plus-strand transcript
(Fig. 3). Interactions with different dsRNAs are discussed in
"T-, W-, and XL-dsRNAs."
Significance of mak and ski (etc.) Mutations
The mutations listed in Table 7 are of direct value in
studies of the killer system since they can be used to
manipulate cellular dsRNA contents. Mutations affecting
toxin secretion, such as krel and -2, skiS, and kexi and -2
(see "Structure of the Ml-dsRNA Preprotoxin Gene and
Steps in Toxin Maturation"), are of considerable interest to
individuals attempting to analyze and optimize protein secre-
tion in S. cerevisiae. It seems likely that the SKI loci (other
than ski5) are involved in relatively general, negative regula-
tion of dsRNA replication (see " [HOK], [EXL], and
[NEX].. .," subsection "Conclusion"). The value of other
mutations may derive principally from analysis of their
effects on basic cell metabolism, as illustrated by the spe,
tcm, and topoisomerase 1 mutations.
It appears that identification of loci affecting killer pheno-
type allows isolation of mutations apparently partially defec-
tive in a wide variety of fundamentally important nuclear
gene products. This is valuable only after identification of
the primary defect, a haphazard process so far, involving the
demonstration of allelism between mutants isolated for ap-
parently independent phenotypes. However, it seems possi-
ble that any mak or other killer mutation resulting in
retarded or temperature-sensitive growth may be worthy of
biochemical analysis if clues to the primary defect can be
elucidated.
Wickner (156) has pointed out that retarded growth is not,
by itself, responsible for Ml-dsRNA loss in mak mutants.
For example, a spe2 ski2 mutant still grows slowly, but
retains Ml. Similarly, a petl8 skil strain remains petite and
temperature sensitive for growth although competent for Ml
maintenance.
EFFECT OF mak AND ski MUTATIONS ON L-dsRNA
MAINTENANCE
Until recently, curing of Ml-dsRNA or loss due to intro-
duction of a mak mutation was not thought to cause loss of
L-dsRNA, although a reduction by about threefold was
observed on introduction of mak3 into a Kl killer (165). One
killer strain, K7, was known to be an exception since
introduction of maklO led to loss of both Ml- and L-dsRNAs
(96). It is now known that this reflects the dependence of LA-
dsRNA maintenance on MAK3, MAKJO, and PETJ8 (41,
129) and that this is the only L species in strain K7; the
residual L-dsRNA in other strains is LBC, which is indepen-
dent of these genes (Table 7). The loss of all L-dsRNA from
strain K7 and the loss of a major fraction of the total L-
dsRNA in other Kl killers during heat curing of the killer
phenotype (151) is similarly due to the temperature sensitiv-
ity of LA but not of LBC maintenance (Table 7). Ml is heat
cured more readily than LA (128) and may have a more
stringent requirement than LA for an unidentified tempera-
ture-labile cell component, or it may simply require a high
LA copy number for its maintenance.
In these experiments (128), it was shown that, after heat
curing of a Kl killer to the point that LA was eliminated from
90% and M1 from 99% of the progeny, the few remaining
killer clones (retaining Ml) all retained LA. This is the most
stringent demonstration of the dependence of Ml on LA.
Maintenance of M2-dsRNA in strains containing L2A is
known to require MAKJO (97). By analogy with the Kl
system, this suggests that L2A shares with LlA at least the
requirement for MAKIO. M2 also requires MAK8 and
MAK16. Other mak loci have not been tested (160). M2 is
heat curable and resembles M1 in all characteristics tested,
except in its requirement for MKT (see next section, subsec-
tion "[NEX], LA-HN, and mktl,2"). No data on M3 have
been reported. A variant of LA, LA-E (see next section), is
atypical in being also dependent on MAK27 (159).
[HOK], [EXL], AND [NEX]: VARIATIONS IN ABILITY
OF LA TO MAINTAIN Ml-dsRNAs
Several variants of LA-dsRNA have been identified by
Wickner and co-workers according to their ability to main-
tain or exclude M2- and M1-dsRNAs in different genetic
backgrounds (128, 129, 157, 159, 167). These are listed in
Table 9 together with their associated plasmid phenotypes,
[HOK], [NEX], and [EXL], and some of their critical
properties. These cytoplasmically inherited phenotypes
were initially defined as unidentified plasmids but are now
known to be phenotypic variants of the LA-dsRNA plasmid.
LlA, the dsRNA normally found in Kl killers, carries [HOK]
and [NEX] phenotypes and so is called LA-HN. L2A, on the
other hand, has only weak [HOK] activity (159) and lacks
[NEX] function. It can mutate to L2A-H, with strong [HOK]
and (EXLR) activity (159) (see below). LA-E and LA-HE are
L-dsRNA species with unique properties which were found
in particular sensitive strains (AN33 and 200, respectively;
157, 159) with no known descent from Kl or K2 killers.
These forms of LA seem to be part of a continuous spectrum
in their ability to maintain Ml- and M2-dsRNAs (Table 9). All
seem less competent for M2- than for M1-dsRNA mainte-
nance.
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TABLE 9. Competence of LA-dsRNA variants for M-dsRNA
maintenancea
MI-dsRNA M2-dsRNA (MKT+LA strains)
variant" Genotype
Genotpe SKSKI+ I k SKI+ K~ k
(LA-E) ski- (LAE) SKI+ ski-
LA-E [EXL] - ± (low) - ND
LA-HE [HOK] [EXL] + + - +
L2A [HOKw] + + ++ _ + +
LA-H [HOK] + + +++ + ++
L2A-H [EXL] [HOK] ND ND ND + + ++
LA-HN [HOK] [NEX] + + +++ + + ++
a The copy number of M-dsRNA maintained ranges from zero (-) through
low (±), moderate (+), to high (+ +). ND, Not determined.
b LA-E = Incompetent for maintenance ofMr- or M2-dsRNA in a SKI+ host;
excludes M,-dsRNA from combination with L2A and maintains M1-dsRNA in
a ski- host at low copy number, a cold-resistant combination;
LA-HE = Competent for maintenance of Ml- but not M,-dsRNA in a SKI+
host; excludes M2-dsRNA from combination with LIA. L2A = Competent for
maintenance of Ml and M2-dsRNA in a SKI+ host at low copy number, but
maintenance of M, is recessive to LA-E; weak ([HOKaJ) L2A-H = (EXLR)
mutant of L2A; now dominant to LA-E for maintenance of both M2 and Ml-
dsRNAs; strong [HOK]. LA-HN (LIA) = Competent for maintenance of Mr-
and M,-dsRNAs at moderate copy numbers in SKI+ hosts (the high levels of
M1-dsRNA supported in ski- hosts leads to cold sensitivity); prevents
exclusion of M. by LA-E, but excludes M2 in a SK1+ mkt- host.
[HOK] and LA-H
The form of LA-dsRNA that is competent for the mainte-
nance of Mr- or M2-dsRNA in a SKI+ nuclear background
(Table 9) is called LA-H, where the H subscript stands for
[HOK], a cytoplasmically inherited genotype originally
called Help Of Killer (157), because of its ability to maintain
a purported Ml-dsRNA mutant called [KIL-sd1] for ski
dependent (167) (see below).
[EXL], LA-E, and LA-HE
A sensitive yeast strain, AN33, was found to harbor a
form of L-dsRNA that, on mating with a K2 killer (carrying
M2- and L2A-dsRNAs) resulted in exclusion of the M2-
dsRNA, producing a sensitive diploid (157). The AN33
plasmid was called [EXL] and later found to be a form of LA-
dsRNA now called LA-E (129, 157, 159).
It is now known that LA-E is incompetent for the mainte-
nance of either M1- or M2-dsRNA in a SKI+ background
(Table 9). In a ski- background, it is able to maintain M1-
dsRNA. [KIL-sd1] is now known to be a combination of
normal M1 with LA-E-dsRNA and a ski- mutation. Thus, the
test for [HOK] is introduction into a SKI' strain of LA-E and
M1 from a ski host. Maintenance of the K1+ R+ phenotype
in the diploid indicates the presence of LA-H in the SKI'
strain, since SKI+ is dominant. Since introduction of LA-H
renders the M1-dsRNA in such strains independent of the ski
mutation, LA-H is either replicated with or excludes LA-E
Conversely, the ability of LA-E to exclude M2 on mating to a
K2 killer means that LA-E excludes L2A or is dominant in its
effect on M2-dsRNA maintenance. It is now known (159;
Ball and Wickner, in press; Wickner, personal communica-
tion) that L2A has weak [HOK] activity, being able to
maintain both itself and either M2- or M1-dsRNA at relative-
ly low copy numbers in a SKI' host. A SKI+ diploid
produced by mating of an LA-E strain with a strain in which
M1 was maintained by L2A is a stable, weak killer retaining
low M1 content (Wickner, personal communication). Pre-
sumably, it also retained low L2A content. Possibly a reduc-
tion in L2A on introduction of LA-E is sufficient to cause
complete loss of M2 but only reduction in M1-dsRNA.
LA-HE is the L-dsRNA found in strain 200 (159). It
excludes M2 on mating with a K2 killer ([EXL] phenotype),
but is capable of maintaining Ml-dsRNA at moderate copy
number in a SKI' background ([HOK] phenotype). It will
maintain both in a ski- background.
L2A and L2A-H (EXLR)
The LA found in natural K2 killers has weak [HOK]
activity. Introduction of LA-E causes loss of M2. After
mutagenesis of such a K2 strain, (EXLR) variants resistant
to M2 exclusion by LA-E were obtained (159). They were
found to have acquired a strong [HOK] phenotype in their L-
dsRNA, which has tentatively been called L2A-H (Table 9).
[NEX], LA-HN, and mktl,2
L1A, the LA-dsRNA normally found in Kl killers, has
strong [HOK] activity. Also, when associated with M2-
dsRNA, it prevents exclusion by [EXL] (LA-E). This pheno-
type is called [NEX] and this LA type is called LA-HN (163).
LIA iS, therefore, LIA-HN. LA-HN is also the LA species found
in sensitive strains S288c and S7, which have been much
used in killer studies. It is the only L-dsRNA found in strain
S7 and killer strains K7, K12, and K23.
LA-HN itself excludes M2 in crosses with K2 killers con-
taining L2A if the haploid segregant contains a defect in
either of two nuclear loci called mktl and mkt2. Exclusion
occurs at 30°C, but not at 20°C (157, 159). The L2A-H mutant
form of L2A has the (EXLR) part of the [NEX] phenotype,
but fails to cause exclusion of M2 in an mkt- strain.
Exclusion of M2 by LA-HN in an mkt- strain is prevented
by a ski2, -3, or 4 mutation, but not by skil. Selection for
further suppressors of M2 exclusion has led to the discovery
of three further ski- loci called ski6, -7, and -8 (114).
Mutations in any of these six ski loci lead to a marked
increase in LA, LBC, and Ml-dsRNA copy number (Ball et
al., in press). An LA-HN Ml ski- combination causes cold
sensitivity which is lost if Ml is removed. This suggests that
M1 replication requires some cell component critical for
growth at low temperature, such as the LTS5 gene product,
that is titrated by a high Ml copy number (114). If LA-E
replaces LA-HN in a ski- strain, Ml copy number is low and
the strain is cold resistant. It has also been observed that the
presence of Ml-dsRNA causes a marked reduction in LA
copy number (Ball et al., in press).
Mutations in three further loci, called mksl, mks2, and
MKS50, were found to suppress [NEX] exclusion of M2 in
mkt strains. These mutants, however, did not portray other
aspects of the ski phenotype (114).
Exclusion of M2- by Ml-dsRNA
Besides exclusion of M2-dsRNA by [EXL], or by [NEX]
in an mkt- background, M2- is excluded by M1-dsRNA (98).
This is unrelated to the LlA HN-dsRNA also present in K1
killers, since cells cured of M1-dsRNA, but retaining LIA-HN-
dsRNA, no longer exclude M2 (159).
Conclusion: Mechanisms of Exclusion and Models for
Control of dsRNA replication
At present, no coherent explanation exists for the interac-
tions of L-dsRNAs with themselves, with Ml- and M2-
dsRNAs, and with the products of SKI, MAK, and MKT
loci. The differential effects of mutations in these loci on
maintenance of different dsRNAs (Table 7) indicate signifi-
cant differences in mechanisms of replication or its control.
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At the same time, the increase in copy number of Ml, M2,
LA-, and LBc-dsRNAs caused by ski mutations suggests
convergence on a pathway negatively controlled by SKI
gene products (Ball et al., in press). Data (our unpublished
observations) suggesting mutual down-regulation of LA and
LBC similarly suggest competition in replication. It would be
surprising if the dsRNAs failed to share common chromo-
somally encoded replication components. Nevertheless, a
chromosomal defect (clo-) in LBC replication has only
recently been recognized (149), and no mutant causing loss
of W- or T-dsRNAs is known (see next section). The known
maintenance mutants can be organized into a converging
hierarchy (Fig. 4), as suggested by Wickner (160). The bias
towards recognition of mutations affecting M- or LA-
dsRNAs clearly reflects the ease with which their loss can be
detected. One suspects that most of the genetic loci indicat-
ed only modulate the efficiency of the actual replication
event and that this scheme should not be regarded as a
biosynthetic pathway. It is not known whether MAK3,10
and PETJ8 are required directly only by LA, or also by Ml.
The dependence of Ml on LA (Fig. 4, positive arrow)
seems clearly related to the provision of capsid peptide. Ball
et al. (in press) suggest, alternatively, that LA helps Ml
maintenance by antagonizing the action of SKI gene prod-
ucts. The reduction of LA-HN in the presence of high Ml in a
ski- strain (114) (Fig. 4, negative arrow) may reflect compe-
tition for a limited capsid supply but might equally reflect
competition for an unidentified limiting cellular component,
such as the MAK 3, 10 or PET18 gene product. Investigation
of the effects of mixing various combinations of LA-E, L2A,
LA-HN, and LBC on their respective copy numbers, in identi-
cal nuclear genetic backgrounds, would clarify some of these
issues. The permutations of presence of M-dsRNAs, ski,
mak, and mkt mutations are obviously large. However,
specific issues should soon be resolved. For example, is L2A
excluded by LA-E and is LA-E itself excluded by LA-HN?
If recognition by capsid is involved in initiation or elonga-
tion events in dsRNA synthesis (14), then exclusion phe-
nomena could arise from competition for capsid between
different transcripts, or from abortive binding of nonhomolo-
M2 MI LA LBC
MAK1. (CL6)\kEE LITS/
IAK3.1
PET18I
(SKI
REPLIC
T,W
,ATION
FIG. 4. Schematic replication pathway illustrating the genetic
requirements of different dsRNAs. All genes are involved in positive
regulation except for the SKI' genes. The positive role of LA on M1
replication is, at least in part, provided by capsid. The negative
effect of M1 on LA copy number is marked in ski2 mutants (Ball et
al., in press). No mutations affecting T or W replication are known.
gous capsid. This implies that [HOK], [NEX], and [EXL]
phenotypes are aspects of capsid structure. This may be-
come clear upon comparison of capsids and capsid genes in
VLPs containing LA-E, LA-HN, and other LA species. The
quite distinct peptide maps for LlA-P1 and L2A-P1, however
(see above, "Role of L-dsRNA Species in Capsid Produc-
tion and Ml-dsRNA Maintenance"), suggest that results
may be difficult to interpret, since both have, or can appar-
ently acquire, M1-specific replication functions implied by
the [HOK] genotype. It seems equally likely that exclusion
phenomena are due to selective competition between
dsRNA species for nuclear gene products required for
dsRNA maintenance. For example, LA-HN and M2 may both
require MKT gene products, although these are not required
(directly) by Ml. Similarly, Ml and M2 may require capsid or
an unidentified gene product, for which Ml competes most
effectively. This type of competition may also explain the
phenotype of suppressive-deletion mutants of Ml-dsRNAs
("Summary of Phenotypes . .," subsection "Plasmid Mu-
tations in Ml-dsRNA").
The variation in properties of LA found in different strains
may reflect either discrete types or the products of rapid
divergent evolution of the dsRNA genome (see "Evolution
of the Killer System"). Thus, LAE may have evolved for
self-maintenance in the absence of a requirement for Ml
maintenance, whereas LlA (LA-HN) has been selected for Ml
maintenance and L2A has been selected for M2 maintenance.
The production of quantities of K2 toxin sufficient for
competition with other yeast strains may require only a
relatively low M2 copy number.
T-, W-, and XL-dsRNAs
lo- and the Discovery of T and W
Discovery of a complex nuclear chromosomal defect
called clo-, which results in failure to maintain LBc at 25°C
(maintenance persists at 30°C or higher temperatures), has
allowed study of two low-copy-number dsRNA species,
unrelated to L and M-dsRNAs, called T and W (149).
Vodkin (141) unexpectedly obtained strains lacking all
detectable dsRNA (including L, M, T, and W) by heavy
ethyl methanesulfonate mutagenesis of killer strain FM11
[PSI+], selection for [PSI'] phenotype (cytoplasmically in-
herited enhancement of nonsense suppression), and screen-
ing for nonkillers. One such strain, JM6 (141), has recently
been found (149) to give a second unexpected result: 2 to 2
segregation of progeny retaining or losing L-dsRNA when
crossed with a petl8 strain presumably containing LBC.
Strain 1815, a segregant of this cross lacking L-dsRNA (L-o
phenotype), contains the clo- ("chromosomal L-o") defect
which results in frequent segregation of L-o meiotic progeny
in crosses to certain strains containing LB but not in crosses
to strains carrying LA or Lc. Because clo- depends on at
least two unlinked chromosomal defects, a karl clO- L-o
strain was constructed and used to test the dependence of
various dsRNAs on CLO+. LB, Lc, and LBC but not LA, M1,
or M2 were found to require CLO+ by this test. The lack of
consistency with the meiotic data on Lc is not understood
(149).
Electrophoretic analysis of the dsRNAs isolated from clo-
L-o strains (149) showed the persistence or enhancement of
two unique bands of 2.7 and 2.25 kb, migrating between L-
and M-dsRNAs, whose presence has frequently been noted
but whose independence of M and L was not previously
apparent. They have been called T (2.7 kb) and W (2.25 kb).
They are inherited cytoplasmically and strains have been
found carrying neither, both, or only W. Thus, T may be
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dependent on W, but neither is dependent on any L-dsRNA.
Maintenance of W is independent of 25 MAK genes tested,
and neither T norW shows cross-hybridization to each other
or to any of the known L- and M-dsRNAs. The copy
numbers of both are increased about 10-fold by growth at
37°C, except in strains carrying an unidentified cytoplasmic
gene. Encapsidation has not been demonstrated; however, a
sucrose gradient peak of T-dsRNA was observed in a crude
extract of cells of a strain containing both T and W,
migrating between ScV-L and free T-dsRNA (149).
Independent dsRNA Families and Their Roles in S.
cerevisiae
At least three apparently independent dsRNA families are
now recognized in S. cerevisiae: LA-dsRNAs and their M-
dsRNA satellites, LBc-dsRNAs, and T and W. Other
dsRNA species may exist, and minor bands in addition to T
and W are frequently seen on electrophoresis of dsRNA
preparations, migrating between L and M. XL, another
minor species, is sometimes observed migrating slightly
slower than L. The relationship of these species to other
dsRNAs is unknown.
None of the three dsRNA families correlates with mito-
chondrial DNA, the 2,um plasmid, [URE3], [PSI], 20S RNA,
or other cytoplasmically inherited phenotypes or genomes
(149, 160), and none of them is apparently required for cell
maintenance in the laboratory. Their role in the wild is also
unknown and their prevalence has not been studied. It is
possible that wild-type homothallic yeasts may segregate
strains containing unique dsRNA species which have only
become mixed in the laboratory. The evidence on "wild-
type" Saccharomyces sp. strains is fragmentary, but sug-
gests no pattern. Thus, most wild-type strains seem to
contain LBC, W, and frequently T and LA. Exceptions are
S3, a maklO L-o strain (T and W content unknown; 127), and
the S. carisbergensis strains Y3795D and NCYC CB11
which lack 2-,um circular DNA and detectable dsRNA. If
these are competent in the wild, then the various dsRNA
species may be merely parasitic, tolerated entities lacking
survival value. The origin of the satellite killer M-dsRNAs is
a separate mystery (see "Evolution of the Killer System").
STRUCTURE OF THE M1-dsRNA PREPROTOXIN GENE
AND STEPS IN TOXIN MATURATION
Toxin Is Derived from a Glycosylated Intracellular Protoxin
The only radiolabeled species specifically immunoprecipi-
tated from extracts of pulse-labeled cells of Kl killers by
antitoxin immunoglobulin G is a 42- to 44-kd species (12).
This species is chased into exocellular toxin with a half-life
of about 25 min at 30°C (24, 25) and so is a protoxin. This
protoxin is converted to a 34- to 35-kd species by endoglyco-
sidase H (12). Since this enzyme cleaves the di-N-acetyl
chitobiose units that link the oligomannosyl side chains in
eucaryotic glycoproteins to asparaginyl residues (132), pro-
toxin is a glycoprotein of this type. This is confirmed by the
effects of tunicamycin, an inhibitor of the synthesis of the
glycosyl donor for this type of protein modification, on
protoxin synthesis. Preincubation of cells with tunicamycin(to exhaust donor) and pulse-labeling reveal a modified
protoxin of about 34 to 35 kd. This is unstable, but chases
only poorly into exocellular toxin (25). Inhibition of glycosy-
lation apparently prevents efficient toxin secretion and labi-
lizes the protoxin to intracellular degradation.
Neither a nor P toxin component is glycosylated (107), so
that the glycosylated portion of protoxin must be removed
during maturation. A model of toxin maturation (see below)
is shown in Fig. 5.
Toxin Is Encoded by Ml-dsRNA Which Also Determines
Immunity
Genetic evidence clearly demonstrates Ml-dsRNA to be
the determinant of both toxin production and immunity.
First, both phenotypes are lost concomitant with loss of Ml-
dsRNA by curing (heat, cycloheximide, etc.) (46, 95, 151).
Second, induced plasmid mutants include both neutral and
suicidal types (24). Like naturally isolated killers and neutral
mutants, these phenotypes correlate with Ml-dsRNA pres-
ence in curing and transmission experiments (7, 24).
The identity of Ml-dsRNA and the killer determinant was
confirmed by demonstrating that Ml-Pl, the 34-kd single
polypeptide comprising more than 90% of the proteins
produced from denatured Ml-dsRNA by a rabbit reticulo-
cyte translation system, contains all of the 20 to 23 Staphylo-
coccus aureus V8 protease-generated peptide components of
secreted toxin (11). The cDNA sequence predicts 24 V8
peptides in mature toxin (see below). Ml-Pl is very similar in
size to deglycosylated protoxin and is specifically immuno-
precipitated by antisera raised against purified toxin (13).
Ml-Pl is also the product of in vitro translation of both the m
and ma single-stranded in vivo transcripts of Ml-dsRNA (9).
Ml-PI was predicted to be identical to the primary in vivo
translation product of Ml-dsRNA, preprotoxin (11). Since
Ml-Pl (34 kd) exceeded the size of toxin (19 kd) and its in
vitro assayed leader peptide (estimated at 1.6 kd; see below)
by about 13 kd, and since toxin was known to lack glycosyla-
tion, it was postulated (11, 12) that a glycosylated fragment
of protoxin is the immunity determinant and that Ml-dsRNA
is monocistronic.
Protoxin Maturation Involves the Normal Protein Secretion
(sec) Pathway
The normal pathway for protein secretion in yeasts resem-
bles that in higher eucaryotic cells and is defined by the
series of temperature-sensitive sec mutants isolated by No-
vick et al. (102-104). A group including secl8 accumulates
secreted proteins in the endoplasmic reticulum (ER) at 37°C
and is blocked in transfer to the Golgi. A single mutant, sec7,
accumulates protein in Golgi structures and has a leaky
block in transfer to secretion vesicles. A third group, includ-
ing secl, is blocked in post-Golgi transfer from secretion
vesicles to the exterior (Fig. 5) (102). Use of these mutants to
study the maturation of invertase demonstrates that core
glycosylation occurs in the ER and elongation occurs in the
Golgi (42). Kl killer strains of sec18, sec7, and secl mutants
all produce protoxin of apparently normal size at 37°C (25),
indicating that most protoxin modifications occur during
cotranslational entry into the ER, with none of the massive
elongation of the carbohydrate chains in the Golgi common
to secreted proteins such as invertase and acid phosphatase
(42), even though protoxin accumulation in sec7 at 37°C
indicates Golgi involvement in toxin secretion (Table 10).
The effects of the presence of dog pancreas membrane
vesicles, a model of ER function (121), on translation of
denatured M1-dsRNA or of the m and ma in vivo transcripts
are consistent with these in vivo results. Ml-Pl (34 kd) is
converted to a mixture of Ml-Pla (about 1.6 kd smaller) and
M1-Plb, the size of protoxin (43 kd) (12). Both species
become protected against added protease (25), so are pre-
sumably located inside the vesicles. Purified Ml-Plb is
converted to M1-Pla by endoglycosidase H (12). It is proba-
ble, therefore, that transport into these vesicles is accompa-
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TABLE 10. Nuclear genes affecting expression of Kl toxin and effects of TPCK
Kl killer Protoxin half-life (min)a
Gene ditlonal pheno- -TPCK CommentsGene
~~~ditional ptype (TeP. CK +TPCK
Wild type K1+ R1j 25 (30) -100 Toxin and other proteins secreted normally
kexi No K- Rj+ 80 (30) -100 No toxin secreted; other secreted proteins
appear normal
kex2 No K- RI+ 15 (30) 15 No toxin or mature at factor secreted; other
secreted proteins larger than normal
kexl kex2 No K- RI+ -100 (30) Phenotype like kexl
secl8 ts (370C)b 80 (37) -100 Blocks transfer from ER to Golgi
sec7 ts (370C) 40 (37) -100 Leaky block in transfer from Golgi to secre-
tory vesicles
secl ts (37°C) 15 (37) -100 Accumulation in secretory vesicles
a Data on half-lives are approximate (25).
b ts, Temperature sensitive.
nied by removal of a 1.6-kd N-terminal secretion leader or
signal peptide by leader peptidase and by asparagine N-
glycosylation. Consistent with this model (see Fig. 5), both
protoxin and mRNA for M1-P1 were found to be membrane
associated in vivo (9).
A more accurate estimate of the size of the peptide
removed by these vesicles is derived from translation of S3-
dsRNA. The deletion in M1-P1 which produces S3 initiates
after 230 bases, within the a toxin peptide region of the Ml-
P1 gene (Fig. 3; see below). The in vitro product of transla-
tion of S3, S3-Pl, is an 8-kd species that is precipitated by
antitoxin immunoglobulin G (12). It is predicted to consist of
the first 72 amino acids of Ml-P1, including 28 amino acids of
a, and a short C-terminal region derived from sequence at
the other side of the deletion, toward the 3' end of the Ml-
dsRNA plus strand (Fig. 3). In the presence of membrane
vesicles, S3-P1 is converted to S3-Pla (6.4 kd), which does
not become glycosylated. It has the normal initiation and
leader sequence but lacks the normal glycosylation sites of
M1-P1. It is undetectable in vivo (12).
These results demonstrate that toxin maturation involves
the normal pathway for protein secretion. Secreted yeast
glycoproteins such as invertase gain a core (GlcNAc)2-
(Man)9-(Glu)3 glycosyl subunit in the ER. The estimated size
of protoxin indicates that it carries three of these 2.5-kd core
subunits.
If this glycosylation event and leader peptidase action
were the only modifications to Ml-Pl in the in vivo synthesis
of protoxin, then endoglycosidase H should convert pro-
toxin to an approximately 32-kd species of the size of the in
vitro Ml-Pla product. Since the deglycosylated protoxin and
the product formed in vivo in the presence of tunicamycin
are the same size as M1-P1 preprotoxin, about 2 kd larger
than expected (12, 25), either additional modifications occur
or the leader peptide removal seen in vitro does not occur in
vivo. Other possible modifications might be O-glycosylation
or palmitoylation, as found for mammalian secreted proteins
(120). Evidence is accumulating that the leader peptide
remains intact and may be responsible for the binding of
protoxin to membranes in vivo (Fig. 5). It has recently been
reported (67), on the basis of parallel data, that secretion into
the ER of the yeast a mating factor precursor, encoded by
the MFoaJ gene, also occurs without removal of the N-
terminal leader. It is possible that maturation events unique
to precursors of secreted proteins, such as protoxin and pro-
a factor, may require the N-terminal attachment of these
precursors to the membranes of the secretion pathway. The
KEX2 function (see below) is a candidate for such an event.
Conversion of Protoxin to Toxin in Secretion Vesicles
Involves a TPCK-Sensitive Protease
Protoxin is stable in a secl8 mutant at 37°C, but has a half-
life of only 15 min in a secl strain at 37°C, where it is chased
into intracellular species of about toxin size. Stability in the
leaky mutant sec7 is intermediate (Table 10). This suggests
that cleavage of protoxin to toxin normally occurs in secre-
tion vesicles (25). This was substantiated by the observation
that tolylsulfonyl phenylalanyl chloromethyl ketone
(TPCK), an inhibitor of chymotrypsin-like proteases, causes
accumulation of protoxin in normal, sec7, or seci mutant
strains at any temperature (Table 10) (25). The maturation of
protoxin in secretion vesicles apparently depends on a
TPCK-sensitive protease (Fig. 5). Tolylsulfonyl lysyl chloro-
methyl ketone, the lysyl analog of TPCK and an inhibitor of
trypsin-like enzymes, failed to stabilize protoxin in vivo (25).
Effects of kexi, kex2, and rex Mutations
Nonconditional mutations in two nuclear loci, KEXI and
KEX2, were found to prevent expression of killing while
allowing normal expression of immunity in a strain carrying
a normal [KIL-kl] plasmid (163). Strains carrying either kexl
or kex2 mutations grow slowly, and the kex2 mutation has a
pleiotropic effect on all exocellular proteins and glycopro-
teins: all are larger and more basic than usual (117). kex2
strains also fail to mate or sporulate (83). They fail to secrete
active a factor (66), secreting instead a massively overglyco-
sylated pro-a factor (67). No such effects are seen in a kexl
strain, but both mutations may affect some step common to
the maturation of unglycosylated secreted proteins. Neither
type of mutant strain secretes an active toxin or antigenically
cross-reactive material. Protoxin is stable in a kexl strain but
unstable in a kex2 strain (Table 10). A kexl kex2 double
mutant behaves like a kexi strain, so that the kexl-deter-
mined step probably precedes that determined by kex2. The
protoxin is not stabilized by TPCK in a kex2 strain (Table
10), suggesting that the KEX2 step precedes exposure to
TPCK-sensitive protease (transfer to vesicles) and that a
kex2 mutation renders protoxin sensitive to a TPCK-insensi-
tive protease system. It is suggested (25; Fig. 5) that KEXI
and KEX2 events occur in the Golgi and that protoxin is
shunted toward the vacuolar degradative machinery if nor-
mal processing is inhibited by a kex2 mutation. Action of the
KEX2 product may protect protoxin from this shunt and
presumably precedes the sec7 event. Investigation of the
biochemical events controlled by these nonessential genes
may illuminate aspects of the yeast secretion pathway pecu-
liar to proteins such as protoxin.
VOL. 48, 1984
 o
n
 June 16, 2019 by guest
http://m
m
br.asm
.org/
D
ow
nloaded from
 
146 TIPPER AND BOSTIAN
[KIL-k1] strains carrying the rexl mutation (150) are
suicidal and kill themselves at pH 4.7. This mutation has not
been studied extensively. It might result in premature toxin
activation, degradation of immunity factor, or modification
of the hypothetical membrane receptor for toxin so that it is
not protected by the immunity determinant.
SEQUENCE OF THE Ml-P1 PREPROTOXIN GENE
Localization Within the dsRNA of a cDNA Covering Most of
the Gene
The in vivo transcripts of M1-dsRNA were fractionated
from the bulk of yeast strain K12-1 polyadenylated RNAs by
virtue of their tight binding to poly(U)-Sepharose and were
used for oligo(dT)-primed cDNA synthesis (K. A. Bostian,
L. Villa-Komaroff, and D. J. Tipper, unpublished data; 10).
After guanine-cytosine tailing and insertion into the PstI site of
pBR322, a 900-bp insert was cloned. This plasmid hybridized
specifically with denatured M1-dsRNA and its transcripts in
Northern blots (9). Sequence analysis of the cDNA (10) and
comparison with the available data on the terminal sequences
of T158c M1-dsRNA (134, 135) (Fig. 6) demonstrated that one
end of the cDNA started with a PstI site encoded in the
dsRNA at bases 111 to 116, counting the pppG at the 5' end of
the plus strand of M1-dsRNA as the first base. The cDNA
sequence corresponding to the N-terminal 20 amino acids of
the a toxin component commences at base 146. Sequence
corresponding to the N-terminal 20 amino acids of the toxin
component commences at base 713, in the same reading frame
as the a component (10). A single TAG stop codon was
found in this frame at bases 962 to 964, and if the 1-
component comprises the entire C-terminal fragment (Fig.
6), its predicted size (83 amino acids; 9.5 kd) corresponds
well to the estimated 9-kd size derived from gel electropho-
resis (Fig. 2). In vivo C-terminal processing of the compo-
nent cannot be excluded on the basis of present data. Both
alternate reading frames have termination codons scattered
throughout the sequence.
Only two ATG triplets, at bases 14 to 16 and 99 to 101,
exist within the dsRNA and cDNA sequence preceding the a
N terminus. Only the former is in frame with the a and
toxin sequences, and labeling of the N terminus of M1-P1
with leucine and valine (20 and 30 amino acids sequenced,
respectively) confirmed that in vitro synthesis initiates at the
former (10). The length of M1-Pl is predicted to be 316 amino
acids, with a molecular weight of 34,787, in good agreement
with gel estimates.
Domain Structure of the Preprotoxin Processing Sites
A domain structure for M1-P1 illustrating its potential
processing sites is shown in Fig. 7. The cleavages producing
the N termini of a and are trypsin-like (Arg-Glu, Lys and
Arg-Tyr, respectively) and are identified as P2 and P4. No
Lys or Arg residues exist between amino acid residues 109
and 148, covering the possible size limits of a, except for the
Arg-Pro sequence at 134 to 135, a sequence which is cleaved
by no known protease type. However, several potential
chymotrypsin-type cleavage sites are clustered in the 120 to
132 region where the C terminus of a probably exists. The
Trp-Gly bond at 130 to 131 (Fig. 6) is the prime candidate for
cleavage by the TPCK-inhibitable enzyme that cleaves pro-
toxin in vivo. This site is located in a generally hydrophilic
area of this rather hydrophobic protein and is likely to be
exposed on the surface of M1-P1. To rationalize the stabiliz-
ing effect ofTPCK on protoxin, and the lack of such an effect
for tolylsulfonyl lysyl chloromethyl ketone, we postulate that
the C terminus of a is produced by a chymotrypsin-like
endoproteolysis (labeled P3, Fig. 7) and that this precedes, and
is required for, access of a trypsin-like enzyme to the P2 and P4
sites.
The remaining preprotoxin processing site, P1 (Fig. 7), is
that which sequence analysis predicts will be hydrolyzed by
leader peptidase during cotranslational transport of Ml-Pl
into the lumen of the ER. The in vitro data using dog
pancreas membranes, indicating a loss of about 14 amino
acids, make it unlikely that the entire 44-amino acid se-
quence preceding a is removed in this first step. Recent
analyses of leader peptidase sites (e.g., reference 109) indi-
cate that all are preceded by a stretch of 8 to 12 primarily
hydrophobic amino acids which may favor a ,B structure in
aqueous and an ax-helical structure in a membrane environ-
ment (32). This stretch is usually preceded by a positively
charged amino acid, which may anchor the preceding region
on the cytoplasmic side of the membrane (109), allowing the
helical hydrophobic region to span the membrane exposing
the leader peptidase site to the lumenal surface (32). This site
consists most commonly of a 13-structure-breaking residue
followed, one to three residues later, by an ala-X-ala se-
quence and a 13 turn, with cleavage occurring after the
second ala residue. Val-X-Ala is the most frequent alternate
cleavage site (109). This pattern is followed in the M1-Pl N
terminus by Arg (residue 10), the hydrophobic stretch Val-
Leu (residues 12 to 21) terminated by His followed by Val-
Val-Ala-Leu (residues 24 to 27). A cotranslational P1 proc-
essing site is predicted at the Ala-Leu (residues 26 to 27)
bond (Fig. 7). A further 18 amino acids would have to be
removed to expose the al N terminus. The discrepancy of the
predicted size of the leader peptide (2.9 kd) with that
observed in vitro (12) is large, and both estimates of the size
of unglycosylated protoxin and experiments on in vivo
expression of the cDNA (see "In Vivo Expression of
Preprotoxin cDNAs") indicate that, in spite of predictions
based on sequence (109), this leader peptide is not cotransla-
tionally removed in yeasts.
All of the AsN-X-Thr/Ser glycosylation sites in M1-Pl
occur in the region between a and 13 that is excised during
processing. This region (-y, predicted to be 103 amino acids;
Fig. 6 and 7) is now the candidate for the immunity determi-
nant (Fig. 5). Both a and 13 contain three Cys residues. No
other Cys residues are found in M1-Pl, so a maximum of
three disulfide bonds could join a and 13. Those shown in Fig.
7 are chosen at random.
Analogies to Insulin and a-FactortMaturation
The maturation of toxin resembles that of insulin (32).
Both are processed by removal of N-terminal and internal
peptides, leaving two disulfide-linked peptides. Terminal
cleavages in both cases occurs within secretion vesicles. A
trypsin-like endopeptidase cleaving at Arg, Lys-X is involved
in both cases. However, the fragment removed in M1-Pl is
much larger than the insulin C peptides (25 to 35 residues).
The insulin C peptide is highly variable in sequence and, it
has been suggested (32), mainly serves to ensure that proin-
sulin exceeds a critical, minimal size for the mammalian
secretion pathway. In larger secreted mammalian proteins
such as insulin-like growth factor, the C segment is much
shorter. A specific function for -y is suggested by its large
size, although it may simply be needed to carry sites for
glycosylation. Glycosylation may be a prerequisite for chan-
neling of a protein through the secretion pathway in yeasts.
Several additional roles for y may be envisaged: first, after
excision, -y may be the immunity determinant; second, as a
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10 20 30 40 50 60 70 80 90
0 ~~0 0 0 0 0 0 0
pppGAAAAATAAMGAA ATG ACG AAG CCA ACC CAA GTA TTA GTT AGA TCC GTC AGT ATA TTA TTT TTC ATC ACA TTA CTA CAC CTA GTC GTA GCG
LMe MehrLys Pro Thr Gin Vai Leu Vai Arg Ser Vai Ser Ile Leu Phe Phe Ile Thr Leu Leu His Leu Val Val Ala
"6"l610 20
100
CTG AAC GAT GTG GCC
Leu Asn Asp Val Ala
(P1)? 30
190
GAT TGG CTA TTA CAG
Asp Trp Leu Leu Gln
60
110P8tI 120 130 140 150t 160 170!,PstI * * * * BglII -
GGT CCT GCA GAA ACA GCA CCA GTG TCA TTA CTA CCT CGT GAA GCG CCG TGG TAT GAC MAG ATC TGG C
Gly Pro Ala Glu Thr Ala Pro Val Ser Leu Leu Pro Arg Glu Ala Pro Trp Tyr Asp Lys Ile Trp C
40 a Toxin > 50
200 210
CGT GCC ACA GAT GGC AAT TGG
Arg Ala Thr Asp Gly Asn Trp
220
GGC AAG
Gly Lys
70
230 240 250
TCG ATC ACC TGG GGT TCA TTC GTA GCG AGC GAT
Ser Ile Thr Trp Gly Ser Phe Val Ala Ser Asp
80
260
GCA GGT
Ala Gly
180
GAA GTA AAA
Glu Val Lys
270
GTA GTA ATC
Val Val Ile
280 290 300 310
TTT GGT ATC AAT GTG TGT MG AAC TGC GTG GGT GAG CGT AAG
Phe Gly Ile Asn Val ry Lys Asn r Val Gly Glu Arg Lys
90 100
370 380 390 400
*
~~~~HpaII
AGC ATT TTm GTA GCA GTT ACA TCC GGC CAT CAT CTT ATA TGG
Ser Ile Phe Val Ala Val Thr Ser Gly His His Leu Ile Trp
120 130
320 330
GAT GAT ATC AGT ACG GAC TGC GGC
Asp Asp Ile Ser Thr Asp M Gly
410 420410 HpaII.
GGT GGT AAT AGG CCG GTG TCG CAG
Gly Gly Asn Arg Pro Val Ser Gln
y Immunity (?)
340 350
AAG CAA ACA CTT GCT
Lys Gln Thr Leu Ala
110
430 440
TCA GAT CCT AAT GGC
Ser Asp Pro Asn Gly
140
460 470 480 490
GCT CGT CGT GAC ATT TCT ACT GTC GCA GAC GGG GAT
Ala Arg Arg Asp Ile Ser Thr Val Ala Asp Gly Asp
150
500
ATT CCA CTC GAC Tm
Ile Pro Leu Asp Phe
160
510 520
AGT GCG TTG AAC GAC ATA TTA
Ser Ala Leu Asn Asp Ile Leu
170
530 540
AAT GAA CAT GGT ATT AGT
Asn Glu His Gly Ile Ser
550 560 570 580 590
ATA CTC CCA GCT AAC GCA TCA CAA TAT GTC AAA AGA TCA GAC ACA GCC GAA
Ile Leu Pro ia Ala Ser Gln Tyr Val Lys Arg Ser Asp Thr Ala Glu
180 190
640 650 660 670 680
HinfI
TTG CAT ACC GAC CTG ATT CAT CAT GGT AAT GGA ACA TAT ACC ACG TTT ACC
Leu His Thr Asp Leu Ile His His Gly As Gly Thr Tyr Thr Thr Phe Thr
210 220
730 740 750 760 770
CCT ATG TGC GAG CAT GGT ATC AAG GCC TCA TAC TGT ATG GCC CTT AAT GAT
Pro Met y Glu His Gly Ile Lys Ala Ser Tyr E Met Ala Leu Asn Asp
240 250
600 610
CAC ACG ACA AGT TTT GTA GTG
His Thr Thr Ser Phe Val Val
200
690 700
ACA CCT CAC ATT CCA GCA GTG
Thr Pro His Ile Pro Ala Val
230
780 790
GCC ATG GTG TCG GCT AAT GGT
Ala Met Val Ser Ala Asn Gly
260
620 630
ACC AAC MAC TAC ACT TCT
Thr Asn Tyr Thr Ser
710 720
GCC AAG CGT TAT GTT TAT
Ala Lys Arg Tyr Val Tyr
$-Toxin
-40
800 810
AAC CTG TAT GGA CTA GCA
Asn Leu Tyr Gly Leu Ala
820 830
* 0
GAA AAG CTG TTT AGT GAG GAT
Glu Lys Leu Phe Ser Glu Asp
270
840 850 860
GAG GGA CMA TGG GAG ACG AAT TAC TAT AM
Glu Gly Gln Trp Glu Thr Asn Tyr Tyr Lys
280
870 880
TTG TAT TGG AGT ACT GGC CAG
Leu Tyr Trp Ser Thr Gly Gln
290
890 900
TGG ATA ATG TCG ATG MAG
Trp Ile Met Ser Met Lys
910 920
* 0
TTT ATT GAG GAA AGT ATT GAT
Phe Ile Glu Glu Ser Ile Asp
300
930 940 950
AAC GCC AMT AAT GAC TTT GAA GGC TGT GAC
Asn Ala Asn Asn Asp Phe Glu Gly 3 Asp
310
960 970 980 9900 BglI 0 0
ACA GGC CAC TAG GGCATCGTGTCTGACCTCTGATGCGATAACTC
Thr Gly His stop
1000 1010
GACCCTACAGAGCA
FIG. 6. Sequence of M1-dsRNA. Sequence from plus-strand bases 1 to 110 is derived from RNA sequencing of the T158c variant (135).
The rest of the sequence derives from the cDNA from wild-type Ml-dsRNA of strain K12-1 (10). The start of preprotoxin at "8" and the N ter-
mini of the a- and 1-toxin components are shown. The start of the -y segment is hypothetical. The cysteine residues potentially involved in
binding a and subunits and the Asn-X-thr/ser glycosylation sites are boxed.
part of protoxin, it may mask the toxin-active site, protecting
the producer cell internal membranes. Third, -y may serve to
direct the folding and disulfide bond formation of a- and ,B-
toxin subunits. The membrane association of protoxin is
unusual and perhaps unique among precursors of secreted
yeast proteins, other than pro-a factor.
Secretion of toxin is strikingly similar to secretion of a
factor in yeasts. This factor is a 13-amino acid peptide
processed from a precursor which, according to its gene
sequence, is a 165-amino acid protein with an N-terminal
secretion leader, a 60-amino acid central region containing
three glycosylation sites, and four tandemly repeated C-
terminal a-factor sequences separated by 6- to 8-amino acid
spacer regions (80). Release of the proximal a-factor precur-
sor occurs by cleavage at Lys,Arg-Glu bonds and is followed
by action of a membrane-associated aminodipeptidase (66).
It has been recently shown (67) that the three sites do
become glycosylated in the ER and fail to become elongated.
360
TTA CTA GTC
Leu Leu Val
450
GCT ACC GTT
Ala Thr Val
VOL. 48, 1984
(
 o
n
 June 16, 2019 by guest
http://m
m
br.asm
.org/
D
ow
nloaded from
 
148 TIPPER AND BOSTIAN
FIG. 7. Schematic domain structure of preprotoxin. Within the N-terminal domain "8," the hypothetical leader peptidase site (P1) (109) is
shown between residues 26 and 27. Processing sites P2 and P4 release the N termini of the a- and p-toxin components. Disulfide bonds drawn
between these two subunits are arbitrarily chosen. The subunits are only separable (in sodium dodecyl sulfate) after reduction (25). The
chymotrypsin-like site between a and y is also hypothetical. Glycosylation (G) sites in y are indicated. Symbols: O, hydrophobic amino acids;
A, acidic amino acids; A, basic amino acids; 0, other.
Cleavage may initiate in the Golgi and occurs mostly in
secretion vesicles. The leader peptide is not removed in the
ER. The similarities in organization and maturation of pre-
protoxin and pre-a factor are obvious, though clear differ-
ences in processing exist. There is no evidence for a role for
aminodipeptidase in protoxin maturation, and kexl does not
affect a-mating-type expression. Since overglycosylation of
pre-a factor occurs in a kex2 mutant (67) and normal glycosyl
chain extension in invertase apparently occurs in the Golgi
(42), this substantiates our prediction of the site of kex2
action as part of traffic control in the Golgi (25) (Fig. 5). Data
on both the MEal and protoxin systems suggest that a
nonglycosylated secreted protein in yeasts must have a
glycosylated precursor and that maturation of these particu-
lar precursors may require retention of the N-terminal leader
sequence as a membrane "anchor."
Functional Analysis of the Toxin Subunit Structure and y
Both a- and p-toxin subunits have a relatively high content
of both charged and hydrophobic amino acids. All of the
excess charge on toxin responsible for its pl of 4.5 resides in
the 3 subunit. This subunit might, therefore, be supposed to
provide the proton binding sites for the cation channels
produced by toxin in target cell membranes. HIowever,
analysis of the preprotoxin sequence for hydrophobicity,
averaged over seven amino acids, shows no long stretches of
adjacent amino acids in ,B with high average hydrophobicity
which could correspond to the membrane spanning regions
of an integral membrane protein (81). In contrast, the a
subunit has two such regions of very high hydrophobicity in
its C-terminal two-thirds (preprotoxin residues 72 to 91 and
112 to 127) separated by a highly hydrophilic region which
contains four acidic amino acid residues and all three of the
cysteine residues of a. It seems likely that spontaneous
insertion of this region of a into a membrane might be
accompanied by a large conformational shift, with topologi-
cal eversion of this region, so that previously buried hydro-
phobic regions interact at their surface with the lipid alkane
chains and the hydrophilic region forms a central hydrated
core, producing the cation channel. Disulfide binding of 1 to
this hydrophilic region in intact toxin could prevent such a
shift, protecting the producer cell membranes against attack.
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The killer toxin may resemble the abrin and ricin class of
toxins in which receptor binding and toxic domains reside on
separate, disulfide-bonded polypeptide chains (106). If so,
then p should have affinity for the 1,6p-D-glucan wall
receptor, interaction with which may labilize its linkage to a,
potentially releasing it for interaction with the membrane
(Fig. 5).
Since the toxin is predicted to attack the cytoplasmic
membrane via a secondary receptor, then immunity factor
might interact with this receptor rather than with toxin. After
processing of protoxin, fusion of secretion vesicles with the
cytoplasmic membrane would expose the hydrophilic, glyco-
sylated portion of Ml-P1 (now predicted to be the -y peptide)
on the exterior of this membrane where the receptor for
toxin presumably exists (Fig. 5). Analysis of hydrophobicity
(81) has shown that, like p-toxin component, the y peptide
has no long hydrophobic region that would correspond to a
membrane-spanning segment. Thus, if membrane associa-
tion occurs, it is presumed to involve binding to a membrane
protein. No means exists for identifying the immunity factor
at present, but coupling of appropriate parts of the Mr-
cDNA to an expression vector (experiments in progress)
should yield a fusion protein which could be used to develop
antisera to search for the -y-peptide sequence in vivo. Experi-
ments on in vivo expression (see below) seem to rule out the
possibility that immunity factor is derived from a separate
reading frame in M1-dsRNA or from the 8 portion of M1-Pl.
Hydrophobicity analysis (81) emphasizes the capacity of
the region of 8 from residues 10 to 29 to form a membrane-
spanning region, consistent with secretion leader functions
and also consistent with a role for 8 in anchoring protoxin to
the membranes of the secretory pathway (Fig. 5). Its ulti-
mate fate is unknown. Fragmentation of M1-dsRNA at the
bubble leads (after denaturation) to in vitro production of a
minor 19-kd translation product, derived from the shorter
600-bp terminal fragment (145). This is not produced from
intact, denatured M1-dsRNA. Although it appears, there-
fore, to be an in vitro artifact, it does demonstrate the
presence of a long open reading frame in this region of M1-
dsRNA that might have significance.
IN VIVO EXPRESSION OF PREPROTOXIN cDNAs
The M1-cDNA sequence has been fused, in frame, to the
5' promoter, upstream control region, and N-terminal secre-
tion leader peptide of the yeast-repressible acid phosphatase
PHOS gene (137). After leader peptidase action, a protoxin
should be produced containing the last 12 amino acids of the
8 region. A sensitive strain transformed with this plasmid
remains sensitive in media with high phosphate content,
but becomes an immune killer in low phosphate (Fig. 1;
S. Hanes, V. E. Burn, D. J. Tipper, and K. A. Bostian, sub-
mitted for publication). Only a fraction of the hybrid prepro-
toxin produced in derepressed cells is converted to toxin.
This fraction is processed to protoxin by leader removal and
glycosylation. The residual hybrid preprotoxin remains un-
modified and may be degraded in the cytoplasm. Inefficiency
of processing in this construction may reflect problems
associated with leader removal and loss of the N-terminal
membrane anchor, inefficiency of insertion of the hybrid
molecule into the ER membrane, or overloading of the
secretion pathway.
It has recently been reported (123, 125) that a similar
cDNA has been prepared from denatured strain TlS8c M1-
dsRNA, using an oligo(dT) primer presumably initiating
within the bubble (16). The cDNA sequence contains an
open reading frame virtually identical to that of the K12-1
preprotoxin (Fig. 5), differing in only four base pairs. Two
amino acid changes occur (Ile 103 to Ser and Thr 123 to Ala),
both in the a subunit, consistent with the observed differ-
ence in a-subunit gel mobility (Fig. 2). The other two
changes, within the y sequence, are silent. The clone ex-
tends further than the K12-1 cDNA in both 3' and 5'
directions. At the 3' end, a 13-bp insert occurs 16 bp
downstream of the TAG stop codon (Fig. 5), and an oligo(A)-
rich region located 15 to 40 bp downstream of our sequence
(Fig. 5) probably indicates the start of the AU-rich bubble.
At the 5' end, it contains most of the preprotoxin leader
sequence. It has been fused, at two locations, to the N
terminus and 5' promoter of the yeast ADH1 gene. Expres-
sion of the fused genes should produce preprotoxins with
modified N termini: one differs in only two of the first three
amino acids, and the other lacks the first nine. Neither
modification affects the hydrophobic membrane-spanning
region of S. Plasmids carrying both fusions, transformed into
a sensitive strain, produce immune killers (D. Thomas,
personal communication).
The results of both promoter gene fusions demonstrate
that the portion of Ml-dsRNA cloned contains all of the
information needed for toxin production and immunity and
strengthen the hypothesis that both functions are contained
within Ml-Pl preprotoxin. These results seem to rule out 8
as an immunity determinant.
The p killer toxin component and a factor are non-
glycosylated C-terminal fragments of glycosylated precur-
sors that carry all of the information used for routing through
the yeast protein secretion pathway. Commercial interest in
the genes for these precursors derives from the hope that
appropriate gene fusions, at the processing sites that result in
release of the C-terminal components, may result in secre-
tion of polypeptides of interest, lacking glycosylation or an
N-terminal prefix. For toxin, this target for gene fusion is the
Lys,Arg-Tyr y-P boundary.
If a DNA plasmid could be designed to give a transcript
with normal Ml-dsRNA termini, then expression of such a
plasmid in a sensitive cell containing ScV-LlA might result in
synthesis of the cRNA strand and encapsidation. This will be
difficult to achieve and not all of the requirements are
understood. However, in this way, stable dsRNA plasmids
containing and expressing an internal sequence of choice
might be synthesizable.
EFFECT OF PLASMID MUTANTS ON TOXIN
MATURATION
Two naturally isolated (Ni and N2) and several ethyl
methanesulfonate-induced (NLP-1 to -10) neutral variants of
M1-dsRNA have been analyzed for expression of the prepro-
toxin gene (Table 11) (24). All have a normal-sized Ml-
dsRNA, except NLP-3, which had a doublet of M-dsRNAs
on agarose gels. Strains NLP-3, -1, and -10 secrete toxin-
sized material reacting with antitoxin and retaining 0.1 to 3%
of normal toxin activity (Table 11), have normal-sized pro-
toxin of normal half-life, and are presumably missense
mutations in the a or p toxin components (24, 25). The
significance of the additional M-dsRNA band in NLP-3 is
unknown. Strains Ni and N2 fail to secrete toxin activity or
CRM, although they produce a protoxin of normal size. This
protoxin was unusually stable in strain Ni and presumably
has a structural modification rendering it resistant to the
TPCK-sensitive vesicular protease. Protoxin stability is no
greater than normal in strain N2. It is either destroyed
intracellularly, possibly being shunted from Golgi to vacu-
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TABLE 11. Expression of preprotoxin genes in Ml-dsRNA mutants (24)
Secreted
M1- Killer In vitro In vivo Prote-
dsRNA pheno- dsRNkA translation protoxin Half-life at Toxin roteain
variant type size (kb) product (kd) (kd) 30°C (mm) activity with
antitoxin
Normal K1+ Ri+ 1.9 34 43 25 100 Yes
NLP-1 K- R1+ 1.9 30 39 25 0 None
-3 K- RI+ 1.9, 1.8 34 43 25 0.15 Yes
-7 K- Ri+ 1.9 34 43 25 0.12 Yes
-10 K- Rj+ 1.9 34 25 3.5 Yes
Ni K- R1+ 1.9 34 43 -100 0 None
N2 K- Rj+ 1.9 34 43 25 0 None
SLP-2 K1+ Rlw 1.7 34 43 25 100 Yes
SLP-4,6 KI+ Rlw 1.9 34 43 25 100 Yes
oles (42), or is secreted and hypersusceptible to exocellular
protease.
The most interesting mutant in this class is NLP-1, which
can be reverted by ethyl methanesulfonate mutagenesis and
is almost certainly, therefore, a point mutation in the M1-Pl
gene (24). It has a normal-sized Ml-dsRNA, but both the in
vitro M1-Pl translation product and the in vivo protoxin are
about 4 kd smaller than normal, suggesting the existence of a
nonsense mutation about halfway through the ,-toxin com-
ponent. This mutant retains immunity, consistent with the y
peptide being the immunity determinant. No toxin activity or
CRM is secreted by this mutant (24).
Several suicidal [KIL-i] mutants were also investigated
(24). The most sensitive is killed only by toxin concentra-
tions 100 times those required to kill the same strain after
curing of its mutant Ml-dsRNA, so it retains weak immnunity.
They all produce normal protoxin and toxin (Table 11) and
presumably are missense mutations in the y component of
protoxin. One strain (SLP-2) has an Ml-dsRNA of reduced
size. This is presumably a consequence of deletion outside of
the Ml-Pl gene, unrelated to the Kl+ R1w phenotype.
The presumed sites of these plasmid mutations are indicat-
ed in Fig. 3. If the immunity determinant is derived from Ml-
P1 and is bound to the outer surface of the cytoplasmic
membrane, then the mutant protoxin in strain Ni or the
normal protoxin stabilized by TPCK might also accumulate
at this site, or even be secreted. However, pulse-labeled
protoxin in TPCK-inhibited cells or in strain Ni is not
secreted and is not solubilized by protoplasting (25). It was
also found (25) that several common proteases mimic in vitro
the normal maturation of protoxin by cleaving Ml-Plb to
relatively stable fragments of the size of the toxin. However,
the accumulated protoxin in neutral strains also fails to
become protease sensitive in protoplasts (25). It appears,
therefore, to remain intracellular. Since protoxin solubiliza-
tion requires detergent treatment of ruptured spheroplasts
(12), it remains membrane associated as in the wild type
under normal conditions.
CODON USAGE IN THE PREPROTOXIN GENE
Extreme bias toward codons recognized by the most
abundant yeast tRNAs is shown in codon usage by mRNAs
for the major yeast proteins, alcohol dehydrogenase isozyme
I, and glyceraldehyde phosphate dehydrogenase (3). Calcu-
lation of a codon bias index and comparison with other
mRNAs shows a direct relationship between this index and
the prevalence of the mRNA (3). The bias ranges from 0.99
for alcohol dehydrogenase I to 0.15 for iso-2 cytochrome c.
A bias of 1.00 would involve exclusive use of the most
abundant tRNAs (underlined in Table 12), whereas a bias of
0 would represent a random choice between the tRNAs
available. The bias calculated for the M1-Pl gene, whose
codon usage is shown in Table 12, is -0.04, indicating a
slight bias against the most common tRNAs. This is clearly
consistent with the low abundance of the preprotoxin
mRNA, as we have determined (Table 6) (10).
LINEAR DNA KILLER PLASMIDS OF K. LACTIS
K. lactis strain ATCC 5356 contains two linear dsDNA
species, pGKl-1 (8.9 kb) and pGKI-2 (13.4 kb), each in about
50 to 100 copies (53). pGKl-1 determines the production of
an exocellular toxin composed of 27- and 80-kd glycoprotein
subunits (51). The plasmids can transform K. lactis confer-
rihg killer phenotype (40). The toxin kills a wide range of
yeasts, including Kluyveromyces, Saccharomyces, Candida,
and Torulopsis sp. strains, and has been shown to inhibit
adenylate cyclase in S. cerevisiae (51), possibly mimicking
the effects of yeast a pheromone. Killers are specifically
immune and both immunity and killing are cytoplasmically
inherited in K. lactis. Transfer of both plasmids to S.
cerevisiae by protoplast fusion or transformation confers the
K. lactis killer and immunity phenotype on the recipient cells
(52). The pGKl-1 plasmid is stable in p0 S. cerevisiae cells,
TABLE 12. Codon usage in the killer preprotoxin genea
Phe UUU
UUc
Leu UUA
UUG
Leu CUU
CUc**
CUA
CUG**
Ile AUU
AUC
AUA*
Met AUG
Val GUU
GUC
GUA*
GUG
9
2
7
3
3
2
6
4
8
7
5
6
4
5
8
8
Ser UCU 2 Tyr UAU
UCC 2 UAC
UCA 6
UCG 4
Pro CCU 5 His CAU
CCC 0 CAC
CCA 5 Gln CAA
CCG** 2 CAG
Thr ACU 3 Asn AAU*
ACC 7 AAC
ACA 10 Lys AAA
ACG 5 AAG
Ala GCU 5 Asp GAU
GCC 8 GAC
GCA 8 Glu GAA
GCG 4 GAG
8 Cys UGU 3
3 UGC 3
Trp UGG
7 Arg CGU**
4 CGC
4 CGA
3 CGG
11 Ser AGU*
8 AGC
3 Arg AGA
10 AGG
11 Gly GGU
10 GGC
8 GGA*
6 GGG
9
6
0
0
0
8
2
2
1
i1
8
3
1
a Data are from the preprotoxin sequence shown in Fig. 6. The codons
recognized by major tRNAs and almost exclusively used by major mRNAs
are underlined. The codons used by preprotoxin and only in the least
abundant of eight mRNAs studied (3) are indicated by *. Those used by
preprotoxin but not even in this mRNA are indicated by **.
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dsRNA KILLER SYSTEM IN YEASTS 151
but becomes unstable if mitochondria are reintroduced to the
S. cerevisiae killers (52). This phenotype bears some resem-
blance to the effect of a maklO mutation on ScV-M1 and
suggests incompatibility between mitochondrial DNA and
the K. lactis plasmids in S. cerevisiae. No such effect is seen
in the petite-negative K. lactis species.
Spontaneous or induced nonkiller mutants of both pGKl-
1-containing K. lactis and S. cerevisiae killers fall into
several classes (101, 147, 148): loss of both plasmids, loss of
only pGKl-1, central or terminal deletions of pGKl-1, and
point mutations in this plasmid. Some of those with central
and point mutations are neutral and retain the immunity
determinant. An open reading frame for 1,146 amino acids in
pGKl-1 presumably codes for a preprotoxin (52), as in the S.
cerevisiae M-dsRNA system, but no data on intracellular
toxin precursors and transcripts, or on the mechanism of
toxin secretion, have been published. K. lactis chromosomal
mutations equivalent to the S. cerevisiae kex mutations have
been isolated (147) and may affect toxin maturation.
The role of pGKl-2 in pGKl-1 maintenance remains con-
jectural. The two plasmids are not encapsidated and bear no
homology either to each other or to nuclear or mitochondrial
DNA.
The termini of pGKl-1 have 202-bp inverted repeats.
Similar 182-bp repeats are found in pGKl-2 (51). They bear
some resemblance, therefore, to the telomeres of yeast
chromosomal DNA and are presumably essentially involved
in replication.
The stability of these plasmids enhances their potential as
cloning vectors. Restriction endonuclease maps are avail-
able (148) and sequencing is in progress. Hybrid plasmids
between pGKl-1 and the S. cerevisiae URA3 gene stably
transform uracil-requiring K. lactis giving URA+ progeny,
but the reisolated plasmids are circular rather than linear, as
anticipated (40).
dsRNA KILLER SYSTEM OF U. MAYDIS
U. maydis, the smut fungus of maize, causes callus
formation in infected tissues and is one of the many plant-
pathogenic fungi (37). Killers of three different immunity
specificities (P1, P4, and P6) have been found among natural
isolates; each type kills the other two but is immune to its
own toxin (72-74, 168). The toxins do not kill S. cerevisiae.
Each killer type is associated with cytoplasmic dsRNAs
individually encapsidated in VLPs (71, 75), including at least
one representative of each of three size classes: heavy (H),
3.6 to 6.2 kb; medium (M), 0.92 to 1.7 kb; and light (L), 0.35
to 0.36 kb. The distribution of dsRNA species of similar size
in representative killer strains are presented in Table 13.
M2(4) and M2(6) refer to the species of M2 size found in P4
and P6 killers, respectively. Since the P6 killer strain carries
only Hi, M2(6), and L, and variants of P1 and P4 killers are
known to lack several of the H components listed (71), it
appears that the minimal requirements for a killer is an H and
an L species plus the appropriate M species: M1(1) for P1,
M2(4) or M3 for P4, and M2(6) for P6 killers.
The U. maydis virus (UmV) VLPs have a single major 75-
kd capsid protein (76) which is probably encoded by one or
more of the H dsRNAs (S. Simon, M. Gorecki, and Y.
Koltin, Genetics 97:s76, 1981), since it is found both in
strains containing only Hi and in related strains containing
only H3 and H4. Toxin production (76) and immunity (108)
segregate with the M-dsRNAs (Table 13) and in vitro transla-
tion of these dsRNAs produces a 19-kd product antigenically
related to the 12-kd toxin (Simon et al., Genetics 97:s76,
1981). The analogy to the ScV system is obvious; however,
TABLE 13. UmV dsRNA sizes and distributiona
dsRNA Size P1 P4 P6(kb)
Hi 6.2 + + +
H2 5.0 + +
H3 3.8 +
H4 3.6 +
Ml (1) 1.7 + (K)
M2 (6) 1.2 + (K)
M2 (1, 4) 1.1 + + (K)
M3 1.1 + +
L 0.36 + + +
a Sizes are approximate (45). The species determining killer phenotype are
indicated by (K). Numbers in parentheses indicate the killer type in which
dsRNAs of similar size are found.
the variety ofH and M species and the presence of L species
are unique.
Northern gel and heteroduplex analyses of the strains
listed in Table 13 demonstrate that the L species in P1 (P1-L)
is entirely derived from one terminus of M1(1), whereas P4-
L is similarly homologous to one end of M2(4) or M3 (M2 and
M3 were not resolved) and P6-L is homologous to one end of
M2(6) (45). The significance of the existence of these small
(0.36-kb) redundant dsRNAs, derived from the killer deter-
minant dsRNAs, is unknown. L is clearly too small to
encode the 19-kd toxin precursor, although it could encode a
7-kd fragment of it, possibly related to immunity.
The Northern gel analysis also demonstrated partial ho-
mology between the killer determinants M1(1) and M2(4) +
M3. Neither is homologous to M2(1) and neither has homolo-
gy to M2(6) (45). This is consistent with the partial overlap of
immunity specificities between P1 and P4, but the lack of
overlap of either with P6 (72).
Probes of Hi from P1, P4, or P6 reacted with the Hi
species of all three types, showing relatedness but not
identity. The same relationship exists between the H2 spe-
cies of P1 and P4 but, surprisingly, Hi, H2, and H3-H4
species are not related, even within the same strain (45). It
seems likely, therefore, that the capsid peptides presumably
encoded by these various H species will also differ, like
those encoded by the ScV LlA-, L2A-, and LBc-dsRNAs. A
complexity at least as great as that seen in the ScV-L system
is apparent in U. maydis.
Limited 3'-sequence analysis has been performed (45) and
demonstrates that, as for the LBc-dsRNAs of S. cerevisiae,
the UmV dsRNAs have either 3'-terminal A-OH or G-OH
residues which are presumed to be unpaired and added post-
transcriptionally.
EFFECTS OF dsRNA MYCOVIRUSES ON PATHOGENIC
FUNGI
As stated in the Introduction, killer phenomena in yeast
presumably have a substantial impact on competition be-
tween related species and (less frequently) between yeast
genera for their favored ecological niche. This may also
apply to pathogenic species which compete for parasitization
of host tissues. The effects of killer plasmids on virulence of
animal pathogenic species such as Candida and Cryptococ-
cus appear to be minimal, and their presence and toxin
susceptibility are only important for epidemiological studies
at present (91, 92, 113). However, effects of mycovirus
infection on the virulence of plant-pathogenic fungi of major
economic importance have been reported and are under
investigation.
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Whereas the killer system in U. maydis is not known to
affect virulence, cytoplasmically inherited dsRNAs found in
certain strains of Endothia parasitica profoundly affect the
virulence of their host (140). Endothia parasitica was intro-
duced into North America early in this century, probably
from the Orient, and virtually eliminated the American
chestnut over the next 50 years. A similar pattern occurred
in parallel in Europe; however, hypovirulent strains causing
a chronic, nonlethal infection developed there. These strains
carry three to five dsRNA species in the size range of 5 to 11
kb, and cytoplasmic transmission of these species correlates
with hypovirulence. They have not been further character-
ized. Although isolated in particles, these particles appear to
be membrane vesicles rich in carbohydrate and lipid, but low
in protein content, rather than encapsidated VLPs (140).
Rhizoctonia solani, a broad-range pathogen for many
economically important crops, has also been found to con-
tain dsRNAs associated with hypovirulence (140). H. victor-
iae, the causal agent of Victoria blight in oats, is itself
susceptible to a "disease" characterized by stunted mycelial
growth, poor sporulation, generalized lysis, and distorted
mycelial cell walls (48). Transmission of these characteris-
tics, which markedly reduce virulence for plants, is associat-
ed with dsRNA-containing VLPs. Serologically unrelated
190S and 145S VLP species are found, containing one and
four dsRNA species, respectively. Healthy, virulent H.
victoriae isolates contain no dsRNA or only the 190S VLPs.
The 145S species is the presumed agent of the disease of the
fungal mycelium and appears to be unstable (48). A low (1%)
but significant rate of disease transmission was observed on
mixing normal H. victoriae protoplasts with VLP prepara-
tions containing both the 190S and 145S species (48). The
145S species may be a satellite virus of the 190S species,
analogous to the relationship between the ScV-M and ScV-
LA species of S. cerevisiae VLPs.
Within the ScV system, killer dsRNA-containing VLPs
have been introduced into commercial fermentation strains
(160) by mating or cytoduction, to guard against the type of
takeover by wild-type killers first observed in sake and beer
fermentations (65, 88).
EVOLUTION OF THE KILLER SYSTEM
As pointed out by Holland et al. (61), RNA genomes are
found only in viruses parasitic on cells with DNA chromo-
somes. They may represent relics of a pre-DNA biosphere or
self-replicating transcripts of a DNA progenitor. They com-
prise most of the disease-causing viruses of eucaryotes and
profoundly affect the survival and evolution of their hosts.
The error-correcting mechanisms inherent in the DNA
synthetic apparatus (e.g., proof-reading exonuclease and
marking of the template strand by methylation) are not
believed to exist in the various RNA-dependent transcrip-
tases, all of which have virus-encoded components, and
evolution of RNA genomes by replication error is rapid, so
that selection for replication efficiency is of major impor-
tance to the survival of these parasitic genomes. Thus, the
frequency of spontaneous temperature-sensitive vesicular
stomatitis virus mutants is about 1 to 2% and silent muta-
tions must occur at similar frequency, 10-4 to 10-5 per
nucleotide per replication (61).
The production of defective-interfering particles, depen-
dent on parental genomes as helper viruses (63), is a graphic
illustration of both the frequency and constraints on RNA
virus mutation. In persistent infection by a mixture of
vesicular stomatitis virus and defective-interfering particles,
mutation and evolution may continue toward a state in which
the virus is almost incapable of forming infectious particles.
If this ability were lost, a plasmid-like state reminiscent of
the mycoviruses would result. Mycoviruses might have
arisen by a similar mechanism, although the absence of
known infectious viruses in fungi may be related to the
excellent protection provided by their cell walls.
Whatever their origin, mycoviruses such as ScV-LA now
exist in apparent amicable equilibrium with their host cells,
producing at least one component essential for their own
survival, but dependent on many host gene products. Muta-
tion to runaway replication has never been observed, proba-
bly because of potential lethality and the absence of trans-
mission. Perhaps more surprising is the stability of ScV-L
"infection" implied by the absence of ScV-free segregants,
in the absence of known physiological advantage conferred
by ScV-L on R- K- host cells. These dsRNA genomes seem
to be peculiarly stable. The origin of the dsRNA species
conferring male sterility on Viciafaba (49) is also unknown.
The origin of the ScV-M killer plasmids, satellites totally
dependent on ScV-LAS, is a different problem. They presum-
ably appeared by acquisition of genes unrelated to dsRNA
maintenance after the L-dsRNA systems were established.
Although they negatively affect ScV-L copy number and
must share some replication components, the lack of homol-
ogy between L- and M-dsRNAs suggests that, if they have a
common origin, their divergence is ancient. Perhaps rare
nuclear RNA recombinational events (splicing errors?) lead to
insertion of information from DNA genes into ScV-L tran-
scripts. The complete killer phenotype would probably have
had to evolve as a DNA system before such an event, since
toxin production and immunity would presumably be insepa-
rable. Both may have derived from a single transmembrane
protein complex involved in controlling cytoplasmic ion
concentrations. Perhaps further investigation of the modes
of action of toxin and immunity may lead to recognition of
normal cellular counterparts of their functional components.
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